Skip to main content
PLOS One logoLink to PLOS One
. 2021 Jul 23;16(7):e0254977. doi: 10.1371/journal.pone.0254977

Facing the COVID-19 pandemic inside maternities in Brazil: A mixed-method study within the REBRACO initiative

Maria Laura Costa 1,*, Renato T Souza 1,#, Rodolfo C Pacagnella 1, Silvana F Bento 1, Carolina C Ribeiro-do-Valle 1, Adriana G Luz 1, Giuliane J Lajos 1, Guilherme M Nobrega 1, Thayna B Griggio 1, Charles M Charles 1, Ricardo P Tedesco 2, Karayna G Fernandes 2, Sérgio H A Martins-Costa 3, Frederico J A Peret 4, Francisco E Feitosa 5, Rosiane Mattar 6, Edson V Cunha Filho 7, Janete Vetorazzi 3,7, Samira M Haddad 8, Carla B Andreucci 9, José P Guida 10, Mário D Correa Junior 11, Marcos A B Dias 12, Leandro G Oliveira 13, Elias F Melo Junior 14, Carlos A S Menezes 15, Marília G Q Luz 16, Jose G Cecatti 1; for the REBRACO Study Group
Editor: Marzia Lazzerini17
PMCID: PMC8301675  PMID: 34297740

Abstract

Introduction

COVID-19 pandemic posed major challenges in obstetric health care services. Preparedness, development, and implementation of new protocols were part of the needed response. This study aims to describe the strategies implemented and the perspectives of health managers on the challenges to face the pandemic in 16 different maternity hospitals that comprise a multicenter study in Brazil, called REBRACO (Brazilian network of COVID-19 during pregnancy).

Methods

Mixed-method study, with quantitative and qualitative approaches. Quantitative data on the infrastructure of the units, maternal and perinatal health indicators, modifications on staff and human resources, from January to July/2020. Also, information on total number of cases, and availability for COVID-19 testing. A qualitative study by purposeful and saturation sampling was undertaken with healthcare managers, to understand perspectives on local challenges in facing the pandemic.

Results

Most maternities early implemented their contingency plan. REBRACO centers reported 338 confirmed COVID-19 cases among pregnant and post-partum women up to July 2020. There were 29 maternal deaths and 15 (51.8%) attributed to COVID-19. All maternities performed relocation of beds designated to labor ward, most (75%) acquired mechanical ventilators, only the minority (25%) installed new negative air pressure rooms. Considering human resources, around 40% hired extra health professionals and increased weekly workload and the majority (68.7%) also suspended annual leaves. Only one center implemented universal screening for childbirth and 6 (37.5%) implemented COVID-19 testing for all suspected cases, while around 60% of the centers only tested moderate/severe cases with hospital admission. Qualitative results showed that main challenges experienced were related to the fear of the virus, concerns about reliability of evidence and lack of resources, with a clear need for mental health support among health professionals.

Conclusion

Study findings suggest that maternities of the REBRACO initiative underwent major changes in facing the pandemic, with limitations on testing, difficulties in infrastructure and human resources. Leadership, continuous training, implementation of evidence-based protocols and collaborative initiatives are key to transpose the fear of the virus and ascertain adequate healthcare inside maternities, especially in low and middle-income settings. Policy makers need to address the specificities in considering reproductive health and childbirth during the COVID-19 pandemic and prioritize research and timely testing availability.

Introduction

Coronavirus disease 2019 (COVID-19) has threatened the world, since March 2020, when the pandemic was officially declared by the WHO (World Health Organization) [1]. Some countries were especially affected and faced individual challenges towards viral dissemination. Brazil, was certainly one of those, recognized as a pandemic hotspot with more than 4.1 million people infected and over 126,000 deaths, in the first 6 months of the pandemic [2]. Brazil is an upper-middle-income country of continental size, with great social and economic disparities among different regions, and major political crisis. These characteristics enhance the challenges in facing a pandemic [3, 4].

The impact of Covid-19 during pregnancy is still under investigation, with many unanswered questions, involving risk of vertical transmission, reinfection, possible increased risk of severe complications, long-term sequels and also concerns involving treatment, fetal assessment, route and timing of delivery [59]. Just as importantly, there are great concerns regarding the indirect effects of the pandemic on the access and availability of healthcare services, especially for women’s health. Differently from other clinical conditions or elective procedures, obstetric care cannot be postponed, and childbirth cannot be rescheduled, and low-resourced settings have been facing a great challenge to ascertain proper care.

Most statistics focus on the number of infected people, hospital admissions and deaths, but little is considered on the efforts to prepare each institution and their health professionals for healthcare during the pandemic. This challenge is even greater in maternity hospitals, many of them with a limited number of beds, especially intensive care unit beds and adequate clinical support. In the earliest stages of the pandemic, the Brazilian Network for Studies in Reproductive and Perinatal Health [10] established a collaborative multicenter approach in Brazil, called REBRACO (Brazilian network of COVID-19 during pregnancy, in Portuguese: REde BRAsileira em estudos do COVID-19 em Obstetrícia). Overall, the REBRACO initiative aimed at evaluating the clinical, epidemiological and laboratory aspects related to SARS-CoV-2 infection during pregnancy, besides a qualitative assessment of women and professionals experiencing such a situation, to identify maternal and perinatal outcomes and collect relevant information to provide quick responses and proper organization of health services to confront the COVID-19 pandemic [11].

As part of the main study, we aim to describe the strategies implemented and the perspectives of health managers on the challenges to face the pandemic in 16 different maternity hospitals of the REBRACO initiative around Brazil, using quantitative and qualitative approaches.

Materials and methods

A national multicenter study (REBRACO) was implemented involving 16 maternity hospitals in Brazil (Fig 1), with data collection considering information retrieved from January/2020 to July/2020. Centers were invited to participate in the study considering their previous experience in other studies in the network. In each participating center, a local PI was identified as responsible for locally supervising the study, plus one or two local coordinators responsible for identifying cases, filling the electronic forms with pertinent information, and performing other activities and procedures of the study.

Fig 1. Brazil political-geographic map showing its federative units (states), and the location of the participating centers of REBRACO.

Fig 1

States colored according to the incidence rate of confirmed cases of COVID-19 per thousand people until July 31, 2020 [2, 12, 13]. Fig 1 was adapted from a map contained in the Brazilian public domain database–Portal Domínio Público (http://www.dominiopublico.gov.br).

Ethical approval for the main study and in each participating center was obtained (Letter of Approval numbers 4.047.168, 4.179.679, and 4.083.988, from the coordinating center´s Institutional Review Board from the University of Campinas, the IRB of the School of Medicine of Jundiai, IRB of the Clinics Hospital of Porto Alegre, the IRB of the Unimed Maternity of Belo Horizonte, the IRB of MEAC from the Federal University of Ceara, the IRB of the Federal University of Sao Paulo, IRB of Moinhos de Vento Hospital from Porto Alegre, IRB of the Jorge Rossmann Regional Hospital from Itanhaem, IRB of the Federal University of Sao Carlos, IRB of the State Hospital of Sumare, IR of the Feral University of Minas Gerais, IRB of the Fernandes Figueira Institute from Fiocruz in Rio de Janeiro, IRB of the School of Medicine from the State University of Sao Paulo in Botucatu, IRB of the Federal University of Pernambuco, IRB of the Climerio de Oliveira Maternity from the Federal University of Bahia in Salvador, and the IRB of the Santa Casa de Misericordia do Pará from Belem.

Quantitative component

For the quantitative component, we collected data on the infrastructure/equipment of the units, maternal and perinatal health indicators, characteristics of service provision and modifications on staff and human resources. All information was retrieved through an electronic form developed by the coordinating center and sent by e-mail to the Principal Investigator of each center (Health Manager, responsible for the Obstetrical Emergency Action Committee—EAC—in each institution). The data collection variables and form are provided as S1 and S2 Datas and includes data on: characteristics of the maternities, their response program, their training program and some indicators related to the COVID-19 pandemic such as the number of cases, number of maternal deaths, maternal mortality ratio due to COVID-19 in the period, the time interval between the implementation of the response program and the first suspected COVID-19 cases in each center and the characteristics of the tests available in the obstetric units.

All suspected cases of COVID-19 in the considered maternities were assessed for informed consent and their data was only included after such consent, with identity kept confidential. Considering biosafety reasons, the study has authorization, by the Institutional Review Board, for both- written informed consent and consent by phone to use information from medical records and sample collection. Mostly suspected cases with hospital admissions have written informed consent, cases that were evaluated and tested in the emergency room, with no needed admission were later consented by phone. The researcher read and explained the consent form and assured that women could withdraw from the study without any interference with planned medical care.

The data sharing information on the questionnaire of readiness towards the pandemic and overall numbers of each institution was approved by the coordinating center and locally in each participating center. Data was stored in a specific database created for this study and protected by password in a de-identified way.

Qualitative component

We also performed a qualitative component, considering key obstetricians involved in the decision making of each institution, to listen to their perspectives on the challenges to face the pandemic in their setting. These participants were identified by local PIs (principal investigators). A qualitative study by purposeful sampling and saturation sampling was undertaken after individual oral consent. All semi-structured interviews were performed by a skilled social researcher with experience in the field and were recorded on audio. For this approach, the Institutional Review Board (IRB) approved the use of oral consent. Maternities considered are in different regions of the country and all interviews were performed by the same researcher in the coordinating center, by telephone, with specific software for further transcription and analysis (“ReShape”), protected by password in a de-identified manner. All interviews were recorded on audio after consent from the participants, using the Microsoft Skype platform.

The semi-structured interview script for health managers, used on the qualitative study is provided as S3 Data. Subsequently, the recordings were verbatim transcribed, and the text obtained checked with the recording. The texts were further inserted in the NVivo® computer program to perform the analysis. Thematic analysis was finally carried out [14] after the familiarization with the collected data. Then we identified the main themes after generating the initial codes. The themes were reviewed and, finally, they were defined and named according to the main challenges identified in the interviewees’ narratives, with their corresponding experiences, conflicts and answers/actions. The analysis was divided into four categories: 1. Preparedness and implementation of actions to fight the pandemic; 2. Taking care of women: information and solutions; 3. Assisting health professionals; 4. The burden of leadership.

In the REBRACO initiative, there are no planned interventions in each included centers. All the research team, including local-PIs, health professionals involved in the local Emergency Action Committees, and other collaborators (Ob&Gyn residents, consultants, etc.) from all the included centers, have been invited to participate in weekly virtual meetings, sharing information regarding the organization of the different health services, the barriers and facilitators in the implementation of healthcare and training of health professionals in each center and discussions on current findings on maternal and perinatal outcomes during pregnancy and postpartum of COVID-19 infected women. These meetings have inspired the current analysis.

Results

Table 1 shows the main characteristics of included maternities in the REBRACO study (n = 16), participating members of the local Emergency Action Committees (EAC) and information on COVID-19 infection and some healthcare indicators. The majority of the centers are public maternities (n = 12) and develops teaching activities (n = 15), with more than 300 deliveries/month, and mostly playing the role of local referral centers for managing COVID-19 suspected and confirmed cases (n = 12). These maternities respond for around 4,000 deliveries per month in the country, with 338 confirmed COVID-19 cases among pregnant and post-partum women up to July 2020. It represented an incidence of 14.9 cases for 1,000 live births. There were overall 29 maternal deaths (distributed in only 7 of the 16 centers) and 15 (51.8%) attributed to COVID-19 (in 6 centers), with a Maternal mortality rate (MMR) of 127.8/100.000 LB.

Table 1. Characteristics of included maternities in the REBRACO study (n = 16), participating members of the local Emergency Action Committees (EAC) and information on COVID-19 infection and some healthcare indicators.

Number of maternities (%)
Characteristics
    Public Maternities 12 (75%)
    Centers with teaching activities 15 (93.8%)
    Deliveries per month
        <300 7 (43.7%)
        ≥ 300 and <500 8 (50.0%)
        ≥ 500 1 (6.3%)
    Referral obstetric unit for COVID-19 cases 12 (75%)
    Access to laboratory diagnostic tests 16 (100%)
    Possibility to test any suspected case of COVID-19 6 (37.5%)
Members of the local Emergency Action Committees (EAC)
    Obstetrics and Gynecology specialist 12 (75%)
    Member of the Infection Prevention and Control Committee 12 (75%)
    Nurse 12 (75%)
    General practitioner or internal medicine 11 (73%)
    Intensive care specialist 11 (68.7%)
    Administrative assistant 11 (68.7%)
    Physiotherapist 5 (31.2%)
COVID-19 infection and Healthcare indicators (Feb-Jul/2020)
    Total confirmed cases among pregnancy/postpartum (n)* 338
    COVID-19 incidence cases** 14,9 / 1,000 LB
    Maternal Death 29
        MD due to COVID-19 (n;%) 15 (51.8%)
    Maternal Mortality Ratio (MMR) 127.8 / 100,000 LB

* Most likely underestimated preliminary result- all centers are auditing their official information to clarify these numbers- mostly these are cases admitted to the hospital. Many centers only test symptomatic cases that need hospital admission.

**There were 22,690 live births in the participating centers in the period (Feb-Jul/2020). LB: live births; MD: Maternal deaths.

All maternities established a local Covid-19 Emergency Action Committee (EAC) and implemented a local protocol for contingency and management of COVID-19 in pregnancy. The EAC was usually comprised of a general practitioner or internal medicine (73% of the centers, n = 11), Obstetrics and Gynecology specialist (75%, n = 12), intensive care specialist (68.7%, n = 11), nurse (75%, n = 12), member of the Infection Prevention and Control Committee (75%, n = 12), administrative assistant (68.7%, n = 11), and, less often, of a physiotherapist (31.2%, n = 5) (Table 1). All the 16 maternities had access to diagnostic laboratory testing. However, only 6 maternities (37.5%) had resources to test any suspected case of COVID-19. Fig 2 shows the characteristics of the tests performed in the REBRACO centers. In half of the centers (n = 8), the tests were not performed in the facility and the characteristics were not available. The characteristic of the RT-PCR and serological tests available were heterogeneous across centers. The majority (n = 10) of the units have tested only suspected cases of COVID-19 that presented with severe symptoms requiring inpatient medical support. Only one maternity implemented universal screening to all women admitted for childbirth (implemented in late June 2020). On average, the test results were available in 4 days. Nine maternities had test results in 2 days or less, while other 2 over 7 days.

Fig 2. Characteristics of the tests for COVID-19 available in the REBRACO centers.

Fig 2

Considering the progression of the pandemic in Brazil, all maternities developed and launched the local C&M protocol, and started training professionals/staff at early stages of the pandemic. One maternity implemented and trained the team in January, one in February, ten maternities in March and four maternities in April 2020 (Fig 3). The mean time between the implementation of the C&M protocol and the identification of the first confirmed Covid-19 case was 71 days. Only one of the maternities registered the first case of COVID-19 before implementing the contingency and management (C&M) protocols. The moment when the first case was identified varied among the maternities (Fig 3): two maternities registered the first case in early March and the majority of the maternities identified the first case in April and May (n = 11).

Fig 3. COVID-19 pandemic progression in Brazil concomitant with the implementation of the contingency and management (C&M) protocols in each REBRACO center.

Fig 3

Horizontal bars represent the interval from C&M implementation and the first confirmed COVID-19 case in each center; blue indicates C&M implementation prior to the first case reported and magenta represents indicates C&M implementation after the first case. The black square in each bar indicates the first case recorded at each center. The star represents the initial date of COVID-19 universal screening at center 1. Turquoise curve represents the cumulative number of confirmed cases in Brazil until July 31, 2020. Vertical dashed line marks the first confirmed case registered in Brazil [2, 13].

An isolated and especially COVID-19 designated private area in the Emergency Room and the medical ward were available in only 12 (75%) and 5 (30%) maternities, respectively. The availability of isolated beds varied according to the size of the maternity measured by the number of deliveries. There was one isolated bed reserved for COVID-19 for every 2.6 deliveries/month in maternities with ≥300 deliveries/month whereas there was one isolated bed for every 15.3 deliveries/month in maternities with <300 deliveries/month. Almost all maternities had an ICU within their hospital (n = 15), and one third had a maternal-fetal ICU in the hospital. Half of the maternities have implemented an isolated and specially designated COVID-19 ICU.

Table 2 shows the modifications and adaptations on infrastructure and human resource policies performed by the maternities during the COVID-19 pandemic. The actions performed included relocation of the designated labor ward, inpatient ward and ICU beds, acquisition of additional mechanical ventilators, and restructuring of the Emergency Room area due to new healthcare flow processes. Redeploying health professionals at higher risk for severe infection away from the highest risk sites and suspension of annual leaves were the most common changes in the staff, followed by hiring more professionals and increasing their weekly workload.

Table 2. Changes on infrastructure and human resources due to COVID-19 pandemic in the REBRACO maternities (n = 16).

Number of maternities (%)
Infrastructure/Equipment
    Resizing the Emergency Room area due to new healthcare flow processes 11 (68.7%)
    Relocation of beds designated to labor ward, medical wards and ICU 16 (100%)
    Installation of negative air pressure room (temporary or definitive solution) 4 (25.0%)
    Acquisition of (new) mechanical ventilators 12 (75.0%)
Staff/Human resources
    Hiring health professionals 6 (37.5%)
    Increases in weekly workload 6 (37.5%)
    Suspension of annual leaves 11 (68.7%)
    Redeploying health professionals at higher risk for severe infection avoiding higher risk sites* 16 (100%)

* Redeploying health professionals at higher risk for severe infection avoiding higher risk sites was recommended by the Brazilian Ministry of Health [15].

Table 3 shows which topics were addressed in the training of the health professionals and how the training sessions were performed. Training on how to proceed orotracheal intubation and cardiopulmonary resuscitation and management of severe acute respiratory syndrome was performed in 11 maternities. Overall, different methods were employed to perform staff training (in loco, written protocol and/or webinars).

Table 3. Training health professionals in the REBRACO maternities (n = 16).

Topic Maternities that performed the training In loco* Written protocol* Webinars (videos)*
Screening/identifying suspected cases 14 (87.5%) 9 (64.2%) 14 (100%) 6 (42.8%)
Putting on and removing PPE 15 (93.7%) 13 (86.6%) 13 (86.6%) 11 (73.3%)
Assistance of severe acute respiratory syndrome 11 (68.7%) 10 (90.1%) 11 (100%) 7 (63.6%)
Proceeding intubation and cardiopulmonary resuscitation 11 (68.7%) 11 (100%) 9 (81.8%) 8 (72.7%)

* The proportion (%) is provided according to the total number of maternities that performed the training of the respective topic. PPE, personal protective equipment.

Results of the qualitative component

All health managers were medical doctors specialized in Obstetrics and Gynecology, aged under 59 years old, and had a PhD degree; half of the participants were women and four of the six were responsible for the Obstetric unit for more than 2 years. The results were divided according to the four analyses categories: 1. Preparedness and implementation of actions to fight the pandemic; 2. Taking care of women: information and solutions; 3. Assisting health professionals; 4. The burden of leadership.

  1. Preparedness and implementation of actions to fight the pandemic

During the COVID-19 pandemic, there was a growing need for developing and implementing new protocols and health care strategies. The experiences related to these processes included a) developing protocols: concerns regarding the source and reliability of the evidence; b) fear of the virus; c) lack of resources: frontline workforce, PPE and lab tests. Fig 4 summarizes the main conflicts and response actions described by the health managers on this topic.

Fig 4. Framework of the conflicts, experiences and response actions on the preparedness and implementations of actions to fight the pandemic according to the health managers.

Fig 4

The middle layer shows the conflicts and the outer layer demonstrates the main actions performed by the health managers and institutions to tackle the main conflicts.

  1. Developing protocols: Concerns regarding the source and reliability of evidence

Excessive information, not always reliable and conflicting recommendations on COVID-19, by different agencies caused insecurity to professionals and raised the need for constant review and update of protocols. Health managers were responsible to review protocols every day or twice a week. As an example, one health manager shared that had to update the institutional protocol 18 times (so far). Growing evidence on a previously unknown disease makes it a challenge to warrant adequate implementation by the health professionals, requiring frequent training and individual and group meetings.

The need for developing protocols and preparing health professionals for fighting the pandemic was not considered a consensus among all the hospital managers and policymakers. According to some health managers, the underestimation of the scale of COVID-19 pandemic and the need for preparedness has established a two-front battle in some of the units. Rapidly, the persistency of health managers in showing evidence-based policies required to fight the pandemic, the reaction from health professionals to the pandemic, and the panorama of what was happening in other countries were crucial to convince them of the need for an early response plan.

  • b

    Fear of the virus

As soon as the first response actions were taken into place, there was a growing fear of providing care to people with suspected or confirmed COVID-19. The uncertainty over the severity and the magnitude of the outbreak in Brazil were the main triggers of fear. Then, the news showing the spread of the virus in other countries and the collapse of their health systems and the great number of deaths that followed. Finally, the fact that health professionals and their families were at higher risk of infection. The fear manifested more strongly when the first patients with suspected COVID-19 started seeking care. The professionals were very scared, cried, and created strategies to avoid working in the frontline (such as missing shifts at COVID-19 ward/frontline). Some medical doctors asked not to provide care to COVID-19 patients and nurses refused to have contact with these patients. Other professionals refused bedside visits, delayed or refused to deliver meals or even to collect samples for laboratory tests. The fear and its consequences resulted in harsh discussions among these professionals and those who were willing to support the patients (they were overloaded).

The fear of the unknown was followed by the fear of being infected and the fear of dying. The limited resources (shortage of beds, ICU, PPE, etc.), an increasing number of deaths, and increase of the workload because of the quarantine of professionals contaminated turned the hospital into a very stressful and toxic work environment. To overcome this challenging scenario, health managers promoted multiple strategies such as small-group discussions on coping with COVID-19 pandemic and on the role of the health professionals, providing mental health services to improve identification and support of related disorders. The role of health care leaders was extremely important to enable all teams to understand how important and critical the role of health professionals is at such difficult times. All these strategies helped to prevent losing the frontline workforce and to create a learning and inclusive environment.

Early during the outbreak, we had a general feeling of fear that was initially resolved. However, when there was no bed available in the city and we started to see people dying near us, there was a big wave of fear again. The [institution] had a mass leave, people who had not given up working began to give up working” (Health Manager 2)

The big challenge is to demystify; we were afraid of attitudes like doctors who overload the other with their work to avoid contamination. Nurses who avoided contact… We did have pleasant surprises, people who also worked very calmly. This is a continuous challenge, as we see medical professionals and mainly nursing professionals talking about getting contaminatedWe have a lot to do with the safety. We try to work with a high level of safety, gold-standards safety procedures and PPE. But this feeling of insecurity still permeates with fear. People, especially when they see colleagues on duty… friends on duty being contaminated” (Health Manager 4)

  • c

    Lack of resources: frontline workforce, PPE and SARS-CoV-2 testing

A great number of health professionals have got temporary leave due to suspected or confirmed COVID-19 or due to mental health disorders. Those comprising the high-risk group for severe illness had been redeployed to different roles. In addition to the lack of health workers in the frontline, some of the obstetric units have experienced a shortage of PPE (gowns/aprons, masks, gloves, etc.) and tests for COVID-19. Health managers became very worried with the lack of availability of PPE and tests caused by the sharpest increase in the price and delayed delivery of such supplies, contributing to widespread stress, fear and emotional distress.

Health managers promoted fundraising strategies for PPE-related expenses, including donations mostly from the health professionals themselves and the private sector companies. Also, campaigns addressing the rational use of PPE and control in deployment were alternatives employed by the health managers to better use the limited resources. Finally, there was pressure for emergency admissions. These efforts were important to demonstrate the commitment to providing a safe workplace.

We created ruleswe are going to restrict the waterproof aprons to this procedure in this sector, we are going to restrict the use of a mask; the mask will have to be used for a given period of time. We increased the time of wearing the masks, we needed to assure availability to [non-Covid] companions as well. I needed to assure masks to the patients. So, we made some masks ourselves. We also made aprons for some sectors; we needed to be creative. Then, we received a lot of donations too. [Donation] Mainly of the face shield, about eight hundred; and fabric to make apronsMask was very difficult; we did not receive [donation] masks… no, we needed to fabricate masks… we received fabric to make the mask”(Health Manager 2)

  • 2

    Taking care of women: information and solutions

Health managers implemented several educational actions in the units, aiming at protecting pregnant women and their families. These strategies included 1) banners, flyers and folders in the maternity, promoting interviews in radio stations and publishing specific content in the maternity social media summarizing what pregnant women should know about COVID-19; 2) telehealth solutions for follow-up of women with suspected or confirmed Covid-19 or for guiding women caring of a newborn (breastfeeding, precautions, bonding, etc.); 3) allocating a multidisciplinary team to provide telehealth guidance (nurse, doctor, social service, etc.).

“We had to create a new program… for all who were interested to participateand the adherence was pretty high (Health Manager 5)

  • 3

    Assisting health professionals

All institutions already had psychological services for health professionals, but now there was an increasing need for facilitating access to such services.

Small group discussions aiming at sharing the same collective challenges helped to increase resiliency, bring back the motivation and show the importance of recognizing their duty and role in the fight against the pandemic. Also, it assisted the identification of those who needed specialized psychological support. Devoting extra attention to the health professionals during this period was positive, providing reassurance at their workplace.

I think that the health professional realized that they can count on us… That they can receive proper care if needed where they workwe and the team are closer now, because the disease can affect anyone. I think that this shared experience helped a lot. (Health Manager 1)

talking with people was really worthyit was really helpful to reduce their and our anguish and anxiety”. (Health Manager 2)

  • 4

    The role and burden of leadership

All health managers felt stressed during the development and implementation of the local C&M protocols. The workload increased, with a great number of virtual meetings and sleep deprivation. While in the professional field they dealt with additional roles in their job position to fight the pandemic. In their personal life, they coped with the loss of colleagues and family members to COVID-19. They needed to extend the time dedicated to working, 24/7 available in some of the periods during the pandemic.

Although challenging and stressful, health managers overall enjoyed being responsible for the job. The commitment of the staff and the opportunity of making the difference were the main motivators.

The experience they had at work has positively affected their life because it was an opportunity to strengthen family bonds. Receiving support and understanding from the family were fundamental to let them cope and deal with multiple tasks during the pandemic, although the routine with the family changed due to the precautions to prevent infection and also because of the lack of time dedicated to partners, children and to focus on exercises or hobbies. Other indirect positive effects were having met other professionals who work on the field and research opportunities. They felt proud for the strong relationship between the members of the C&M group and health professionals, generating a “feeling of brotherhood”.

Most of the health managers mentioned that they felt challenged because, in fact, “the feeling of great responsibility” or “as if we were going to war”. There was a mixture of feelings and challenges such as being overwhelmed but having support from the families and the staff. Some of the health managers themselves had suspected, but not confirmed, cases of COVID-19, which raised more concerns regarding the safety of their family.

There are relevant personal lessons from the response to the pandemic: to keep a constant dialogue with the health professionals; greater interaction between professionals from different maternity sectors, keeping an inclusive and learning atmosphere, the importance of safety procedures (importance of hand hygiene and use of PPE); improved patient orientation after discharge.

I often felt challenged… feeling challenged every day. This basically didn’t bring me a bad feeling all the time, didn’t bring me anxiety, but a feeling of contentment whenever we managed to finish a task.” (Health Manager 2)

“The biggest challenge was the leadership, the task job of gathering people together and keeping alive the purpose of collaboration that already existed without creating any rupture in the new scenario. That was not easy. (Manager 4)

Discussion

The 16 maternities of the REBRACO initiative were mostly university hospitals, which underwent major changes and adaptations in facing the first few months of the pandemic, resizing emergency rooms, relocating beds and adding extra ICU units, with acquisition of ventilators. On human resources, most centers had to employ increased weekly workloads, deal with medical leave due to COVID infections, and hire extra health professionals. Listening to health managers, main concerns included fear of the virus and lack of resources. There was a clear limitation in the capacity of testing during the considered study period, less than half of the centers had resources to test any suspected case of COVID-19.

The challenge to translate evidence into practice during a pandemic, to update clinical protocols, and establish the best possible provision of healthcare and interventions with hundreds of daily publications is many times overwhelming. Not only that, but to guarantee preventive measures to patients and healthcare providers is key in facing Covid-19 and working in the complete chain of care, through primary care to the referral center [16, 17]. Under-resourced settings are at increased risk and challenge. Outcomes in such settings seem not as reported and reliable data is still not available to conclude.

Preparedness is based on pre-existing knowledge and resilience, although during a pandemic of a previously unknown disease, not only on its course but also on its mode and period of transmission, it is not too straightforward. Previous knowledge of similar diseases is the cornerstone helped build the response. The goals are always to prevent the intra-institutional spread and to ascertain that safe, timely and adequate care is offered to patients [18].

The pandemic is overstretching health systems worldwide, more so where the health systems have underlying fragilities. A recent report using data from the Brazilian national surveillance system on severe respiratory disease, presented a very high number of maternal deaths, with special attention to postpartum mortality and with information on delayed healthcare, since a significant number of cases did not receive respiratory support or admission to intensive care units [19], while other studies presented overall low mortality during gestation [20].

Due to the low number of performed tests among the overall population, it is possible, however, that the mortality index reported by the Brazilian study may be overestimated. Delays have already been highlighted among pregnancies for severe maternal morbidity long ago, showing a clear and significant association among frequency of delay and severity of outcome, indicating that timely and adequate management is correlated to survival [21], and the urge of a pandemic can only exacerbate such limitations.

The three delays model, by Thaddeus and Maine, defines three major components or phases: phase I–delay to seek care by the individual and/or family, phase II–delay in reaching an adequate health care facility, and phase III–delay in receiving adequate care at the health facility [22]. All these are key towards improving outcomes in COVID-19. Possibly the finding that not all participating centers had the strategy of training their health professionals on the assistance of severe acute respiratory syndrome and proceeding intubation and cardiopulmonary resuscitation could, at least in part, explain the severity level and the high associated mortality as described for the country. In the considered centers, there were 15 maternal deaths due to COVID-19, however, 12 deaths occurred in the North and Northeast regions (worst HDI- Human Development Index), what corroborates to previous data on worse outcomes in under-resourced settings.

A major limitation in many settings, as shown in the current results, is the restricted availability of testing for SARS-CoV-2 and when available, the delayed turnover of results and heterogeneity of the characteristics of the tests across centers [2325]. This has a special impact in pregnancy, because of the needed follow-up of maternal and fetal assessment depending on gestational age, the decision on the timing of delivery and all the implications of needed protective equipment for a safe childbirth procedure, including the neonate and the corresponding health team. However, adequate or even intensive care to women with severe signs should always be timely performed even before the results of testing, avoiding phase III delays, as previously discussed. In addition, the heterogeneity of tests makes the comparison of the incidence of COVID-19 cases more difficult, which increase challenges on the response to the pandemic using such epidemiological information.

Not only that, but the impact considering suspected cases, in restriction of companionship during childbirth, delayed mother-child contact after delivery and excessive interventions, including increased risk for cesarean section. Even with growing evidence supporting the maintenance of health care that preserves a positive experience during childbirth [16], this is not always respected in many maternities worldwide.

The EAC within each facility were established to develop and manage strategies of preparedness and response, and to develop continuous planning, which includes updating policies and protocols. Moreover, the COVID-19 pandemic required changes in the maternity workforce and equipment resources. The role of the EACs and support by the REBRACO study group, in the Brazilian context, was considered important because there has been conflicting information from medical societies, local and federal governments, public health agencies, and the Brazilian Ministry of Health. Also, there have been limited resources and support available for the maternal and perinatal health area from national agencies. Up to August/ 2020, there was no national guidance specific for pregnancy. Coordinated efforts should be the rule for adequate support to health facilities [26].

Previous experience, during the Influenza A H1N1 pdm09 epidemic showed that infection during pregnancy was associated with severe maternal morbidity (SMM) and, consequently, with increased adverse perinatal outcomes such as low birth weight, preterm deliveries, stillbirths, neonatal and maternal mortality [27]. The availability of ICU and proper management of maternal morbidity cases were associated with a reduction of maternal near-miss and maternal deaths among women with SMM [28]. Nevertheless, there is current evidence that a significant proportion of pregnant women who died due to COVID-19 in Brazil did not have access to an ICU [19]. Providing adequate training, assuring safe workplaces and sufficient intensive care units remain unmet needs in the fight against the pandemic in Brazil.

The qualitative approach has raised interesting experiences related to the development and implementation of an emergency action committee to respond to the pandemic in obstetric units. The health managers described how fear has affected all stages of the response to the pandemic, including preparedness and implementation of protocols and the daily attendance routine in obstetric units. The “pandemic fear” phenomenon has been reported worldwide in the context of the COVID-19 and the healthcare services [2931]. The absence of effective treatment, non-availability of vaccine during the first wave, and the possibility of a collapse in the health system has only worsen the scenario [32]. The response of health care services towards the pandemic affects how people experience and react to challenges [29, 33].

In fact, some key components for rapid hospital readiness involve leadership, coordination, communication, and community engagement [26]. Without these components, people, including health professionals, may feel unsupported. The provision of these skills may enhance the ability of health facilities in organizing their crisis management plans and to ensure informed risk analyses, decision-making strategies, and confidence amongst all hospital staff and stakeholders. Also, a multi-strategy approach is essential to provide mental health support to health professionals during the pandemic, including multidisciplinary mental health teams, clear communication involving regular and accurate updates on the COVID-19 outbreak and safe psychological counselling services (e.g. via electronic devices or apps) [32, 34]. The institutions considered in this study, mostly university hospitals and referral centers, had availability for such support, what might not be true or representative of most maternities in Brazil.

The healthcare managers are in a leadership position, which demands dealing with challenging dilemmas such as lack of health professionals, fear of the staff in working in the frontline and lack of resources at the very same moment when the workforce and such resources are needed the most. Dealing with extra work and with personal issues and worries requires resiliency, persistency and the ability to adapt and listening. Improving health care leadership is of great importance as part of the response to the pandemic, especially when there are conflicting policies by governors and policy-makers [3].

As a limitation of the current REBRACO study, data from the 16 maternity centers included is not representative of the real maternal health care throughout Brazil, a country of continental size and major disparities. Therefore, the presented results do not provide data to ascertain improved clinical outcomes among considered maternities. In addition, as previously informed, the centers did not follow a common standard protocol for clinically dealing with cases of Covid19 during pregnancy, because only very recently the Ministry of Health issued general recommendations for such management.

Details on how maternities prepared to face the Covid-19, with quantitative and qualitative approaches in a middle-income setting that was severely affected by the disease, using institutions that are part of a National Network for Studies in Reproductive and Perinatal Health can help health managers and professionals in facing not only the current but also future challenges. Additionally, prospective evaluation on short and long-term clinical and social determinants of the coronavirus disease in Brazil will add to epidemiological reports [35, 36], the main dataset available so far in the country.

Conclusions

Study findings suggest that maternities of the REBRACO initiative underwent major changes in facing the pandemic, with limitations on testing, difficulties in infrastructure and human resources. Leadership, continuous training, implementation of evidence-based protocols and collaborative initiatives are key to transpose the fear of the virus and ascertain adequate healthcare inside maternities, especially in low and middle-income settings. Policy makers need to address the specificities in considering reproductive health and childbirth during the COVID-19 pandemic and prioritize research and timely testing availability.

Supporting information

S1 Checklist. STROBE statement—checklist of items that should be included in reports of observational studies.

(DOCX)

S1 Data. Variables requested for the characterization of the included REBRACO centers.

List of variables which were collected through online forms.

(DOCX)

S2 Data. Data collection form.

Information about the organization, health care and consolidated results of the REBRACO participating centers (from March to August).

(DOCX)

S3 Data. Interview script.

Semi-structured interview script for health managers, used on the qualitative study.

(DOCX)

Acknowledgments

We would like to recognize the participation of the other members from the REBRACO Study Group leaded by Jose G Cecatti (cecatti@unicamp.br): Sherly Metelus1, Amanda D Silva1, Paulo S R Junior1, Thais G Sardinha1, Rodolfo R Japenga1, Erica R F Urquiza1, Maíra R Machado1, Marcela Maria Simões1, Larissa M Solda1, Patrícia B Peres2, Cristiane L Arbeli2, Rafael M Quevedo2, Carolina F Yamashita2, Julia D Corradin2, Isabella Bergamini2, José Geraldo L Ramos3, Maria Lúcia R Oppermann3, Laisa S Quadro3, Lina Marins3, Érika V Paniz3, Aline C Costa4, Marina HL Almeida4, Bruna FV Moura4, Lidiane R França4, Hanna Vieira4, Rafael B Aquino4, Daisy Lucena5, Feitosa L Pinheiro5, Denise H F Cordeiro5, Priscila L Miná5, Carol Dornellas5, Evelyn Traina6, Sue Yazaki-Sun6, Priscilla Mota6, Arimaza C Soares6, Ellen Machado7, Anne Bergmann7, Gustavo Raupp Santos7, Aline Tosetto8, Sabrina Savazoni8, Bruna E Parreira9, Rayra AM Maciel11, Caio RV Leal11, Marcos Nakamura-Pereira12, Bruna O Guerra12, Gabriela Gorga12, Kevin FA Oliveira13, Débora F Leite14, Isabella Monteiro14, Cristiane O Santos15, Marina M dos Santos15, Carlos Neto15, Thiago Gomes15, Isabela R Pereira16, Clélia A Salustrino16, Valéria B Pontes16, Roberto AS Franco16, João P Bilibio16, Gislânia PF Brito16, Hana PC Pinto16, Danielle L Oliveira16, Andrezza A Guerra16, Andrea O Moura16, Natasha Pantoja16, Fernanda David16, Alina Silva16. Also, we would like to acknowledge the staff from the coordinator centre which has had a major contribution as part of the REBRACO initiative: Angela M Bacha, Anderson Borovac-Pinheiro, Belmiro G Pereiro, Fernanda G Surita, Eliana M Amaral, Elton C Ferreira, Helaine M Milanez, Jamil P S Caldas, Luis Bahamondes, Luiz F Baccaro, Marcelo Nomura, Patrícia M Rehder, Renata Zacarias Simone, Renato Passini Jr, Sergio T Marba and Tábata R Zumpano Santos.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding source of support during this study was FAEPEX-Unicamp (Fundo de Apoio ao Ensino, à Pesquisa e à Extensão) under grant number 2300/20.

References

  • 1.WHO. World Health Organization. Coronavirus disease 2019 (COVID-19). Situation Report– 51. 2020 [cited 12 Aug 2020]. Available: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10
  • 2.COVID-19 Map—Johns Hopkins Coronavirus Resource Center. In: COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University [Internet]. 2020 [cited 12 Aug 2020]. Available: https://coronavirus.jhu.edu/map.html
  • 3.Lancet The. COVID-19 in Brazil: “So what?” The Lancet. Lancet Publishing Group; 2020. p. 1461. doi: 10.1016/S0140-6736(20)31095-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Baqui P, Bica I, Marra V, Ercole A, van der Schaar M. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study. The Lancet Global Health. 2020;8: e1018–e1026. doi: 10.1016/S2214-109X(20)30285-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Huntley BJF, Huntley ES, Di Mascio D, Chen T, Berghella V, Chauhan SP. Rates of Maternal and Perinatal Mortality and Vertical Transmission in Pregnancies Complicated by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Co-V-2) Infection. Obstetrics & Gynecology. 2020;136: 303–312. doi: 10.1097/AOG.0000000000004010 [DOI] [PubMed] [Google Scholar]
  • 6.Walker KF, O’Donoghue K, Grace N, Dorling J, Comeau JL, Li W, et al. Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: A systematic review and critical analysis. BJOG: An International Journal of Obstetrics and Gynaecology. Blackwell Publishing Ltd; 2020. doi: 10.1111/1471-0528.16362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Trocado V, Silvestre-Machado J, Azevedo L, Miranda A, Nogueira-Silva C. Pregnancy and COVID-19: a systematic review of maternal, obstetric and neonatal outcomes. Journal of Maternal-Fetal and Neonatal Medicine. Taylor and Francis Ltd; 2020. pp. 1–13. doi: 10.1080/14767058.2020.1781809 [DOI] [PubMed] [Google Scholar]
  • 8.Capobianco G, Saderi L, Aliberti S, Mondoni M, Piana A, Dessole F, et al. COVID-19 in pregnant women: A systematic review and meta-analysis. European Journal of Obstetrics and Gynecology and Reproductive Biology. 2020. doi: 10.1016/j.ejogrb.2020.07.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Thomas P, Alexander PE, Ahmed U, Elderhorst E, El-Khechen H, Mammen MJ, et al. Vertical transmission risk of SARS-CoV-2 infection in the third trimester: a systematic scoping review. Journal of Maternal-Fetal and Neonatal Medicine. Taylor and Francis Ltd; 2020. doi: 10.1080/14767058.2020.1786055 [DOI] [PubMed] [Google Scholar]
  • 10.Cecatti J, Costa M, Haddad S, Parpinelli M, Souza J, Sousa M, et al. Network for Surveillance of Severe Maternal Morbidity: a powerful national collaboration generating data on maternal health outcomes and care. BJOG: An International Journal of Obstetrics & Gynaecology. 2016;123: 946–953. doi: 10.1111/1471-0528.13614 [DOI] [PubMed] [Google Scholar]
  • 11.Costa ML, Pacagnella RC, Guida JP, Souza RT, Charles CM, Lajos GJ, et al. Call to action for a South American network to fight COVID‐19 in pregnancy. International Journal of Gynecology & Obstetrics. 2020;150: 260–261. doi: 10.1002/ijgo.13225 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.IBGE–Instituto Brasileiro de Geografia e Estatística. 2010 Demographic Census; Table 1.4—População nos Censos Demográficos, segundo as Grandes Regiões e as Unidades da Federação—1872/2010. 2010. Available: https://censo2010.ibge.gov.br/sinopse/index.php?dados=4&uf=00
  • 13.Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases. Lancet Publishing Group; 2020. pp. 533–534. doi: 10.1016/S1473-3099(20)30120-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Machado-da-Silva CL. Qualitative research & evaluation methods. Revista de Administração Contemporânea. 2003;7: 219–219. doi: 10.1590/s1415-65552003000200018 [DOI] [Google Scholar]
  • 15.Ministério da Saúde. Recomendações de proteção aos trabalhadores dos serviços de saúde no atendimento de COVID-19 e outras síndromes gripais. Ministério da Saúde. Secretaria de Vigilância em Saúde, COE/SVS/MS. 2020. [Google Scholar]
  • 16.WHO. World Health Organization. Clinical management of COVID-19. Interim guidance. WHO reference number: WHO/2019-nCoV/clinical/2020.5. 2020 [cited 12 Aug 2020]. Available: https://www.who.int/publications/i/item/clinical-management-of-covid-19
  • 17.Hick JL, Biddinger PD. Novel coronavirus and old lessons—Preparing the health system for the pandemic. New England Journal of Medicine. Massachussetts Medical Society; 2020. doi: 10.1056/NEJMp2005118 [DOI] [PubMed] [Google Scholar]
  • 18.Toner E, Waldhorn R. What hospitals should do to prepare for an influenza pandemic. Biosecurity and Bioterrorism. Biosecur Bioterror; 2006. pp. 397–402. doi: 10.1089/bsp.2006.4.397 [DOI] [PubMed] [Google Scholar]
  • 19.Takemoto MLS, Menezes M de O, Andreucci CB, Nakamura‐Pereira M, Amorim MMR, Katz L, et al. The tragedy of COVID‐19 in Brazil: 124 maternal deaths and counting. International Journal of Gynecology & Obstetrics. 2020; ijgo.13300. doi: 10.1002/ijgo.13300 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hessami K, Homayoon N, Hashemi A, Vafaei H, Kasraeian M, Asadi N. COVID-19 and maternal, fetal and neonatal mortality: a systematic review. Journal of Maternal-Fetal and Neonatal Medicine. Taylor and Francis Ltd; 2020. doi: 10.1080/14767058.2020.1806817 [DOI] [PubMed] [Google Scholar]
  • 21.Pacagnella RC, Cecatti JG, Parpinelli MA, Sousa MH, Haddad SM, Costa ML, et al. Delays in receiving obstetric care and poor maternal outcomes: results from a national multicentre cross-sectional study. BMC pregnancy and childbirth. 2014;14: 159. doi: 10.1186/1471-2393-14-159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Thaddeus S, Maine D. Too far to walk: maternal mortality in context. Social science & medicine. 1994;38: 1091–110. doi: 10.1016/0277-9536(94)90226-7 [DOI] [PubMed] [Google Scholar]
  • 23.Zar HJ, Dawa J, Fischer GB, Castro-Rodriguez JA. Challenges of COVID-19 in children in low- and middle-income countries. Paediatric Respiratory Reviews. W.B. Saunders Ltd; 2020. pp. 70–74. doi: 10.1016/j.prrv.2020.06.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bong CL, Brasher C, Chikumba E, Mcdougall R, Mellin-Olsen J, Enright A. The COVID-19 Pandemic: Effects on Low- And Middle-Income Countries. Anesthesia and Analgesia. 2020;131: 86–92. doi: 10.1213/ANE.0000000000004846 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Dzinamarira T, Dzobo M, Chitungo I. COVID-19: A perspective on Africa’s capacity and response. Journal of Medical Virology. John Wiley and Sons Inc; 2020. pp. 2465–2472. doi: 10.1002/jmv.26159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.World Health Organization. Rapid hospital readiness checklist: Interim Guidance. [cited 31 Aug 2020]. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-hospital-readiness-checklist-2020.1
  • 27.Pfitscher LC, Cecatti JG, Pacagnella RC, Haddad SM, Parpinelli MA, Souza JP, et al. Severe maternal morbidity due to respiratory disease and impact of 2009 H1N1 influenza A pandemic in Brazil: Results from a national multicenter cross-sectional study. BMC Infectious Diseases. 2016;16. doi: 10.1186/s12879-016-1338-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Soares FM, Guida JP, Pacagnella RC, Souza JP, Parpinelli MÂ, Haddad SM, et al. Use of Intensive Care Unit in Women with Severe Maternal Morbidity and Maternal Death: Results from a National Multicenter Study. Revista Brasileira de Ginecologia e Obstetricia. 2020;42: 124–132. doi: 10.1055/s-0040-1708095 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Skoda E-M, Teufel M, Stang A, Jöckel K-H, Junne F, Weismüller B, et al. Psychological burden of healthcare professionals in Germany during the acute phase of the COVID-19 pandemic: differences and similarities in the international context. Journal of Public Health. 2020. doi: 10.1093/pubmed/fdaa124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lee SA, Crunk EA. Fear and Psychopathology During the COVID-19 Crisis: Neuroticism, Hypochondriasis, Reassurance-Seeking, and Coronaphobia as Fear Factors. Omega; (United States: ). 2020. doi: 10.1177/0030222820949350 [DOI] [PubMed] [Google Scholar]
  • 31.Giusti EM, Pedroli E, D’Aniello GE, Stramba Badiale C, Pietrabissa G, Manna C, et al. The Psychological Impact of the COVID-19 Outbreak on Health Professionals: A Cross-Sectional Study. Frontiers in Psychology. 2020;11. doi: 10.3389/fpsyg.2020.01684 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ornell F, Schuch JB, Sordi AO, Kessler FHP. ‘“Pandemic fear”‘ and COVID-19: Mental health burden and strategies. Brazilian Journal of Psychiatry. Associacao Brasileira de Psiquiatria; 2020. pp. 232–235. doi: 10.1590/1516-4446-2020-0008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Lazzerini M, Barbi E, Apicella A, Marchetti F, Cardinale F, Trobia G. Delayed access or provision of care in Italy resulting from fear of COVID-19. The Lancet Child and Adolescent Health. Elsevier B.V.; 2020. pp. e10–e11. doi: 10.1016/S2352-4642(20)30108-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Greenberg N, Docherty M, Gnanapragasam S, Wessely S. Managing mental health challenges faced by healthcare workers during covid-19 pandemic. doi: 10.1136/bmj.m1211 [DOI] [PubMed] [Google Scholar]
  • 35.Ministry of Health, Brazil. SRAG 2020—Banco de Dados de Síndrome Respiratória Aguda Grave—incluindo dados da COVID-19. In: Vigilância de Síndrome Respiratória Aguda Grave (SRAG) [Internet]. 2020. Available: https://opendatasus.saude.gov.br/dataset/bd-srag-2020
  • 36.Ministry of Health, Brazil. Painel de casos de doença pelo coronavírus 2019 (COVID-19) no Brasil pelo Ministério da Saúde. In: Version 2.0 [Internet]. 2020. Available: https://covid.saude.gov.br/

Decision Letter 0

Marzia Lazzerini

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

5 Jan 2021

PONE-D-20-29941

Facing the COVID-19 Pandemic inside maternities in Brazil: how to overcome challenges towards adequate careFacing the COVID-19 Pandemic inside maternities in Brazil: how to overcome challenges towards adequate care

PLOS ONE

Dear Dr. Costa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please read carefully all comments below before resubmitting your paper. 

Please submit your revised manuscript by Feb 19 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Marzia Lazzerini, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for including your ethics statement: "Ethical approval 81 for the main study and in each participating center was obtained (Letter of Approval numbers 82 4.047.168, 4.179.679, and 4.083.988)."   

 a.Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study.

 b.Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

 For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research.

3. For your cross-sectional study, please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was obtained for the questionnaire (2) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed).  If the need for consent was waived, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent.

4. Regarding verbal consent in your qualitative study, in the Methods, please state:

- Why written consent could not be obtained

- Whether the Institutional Review Board (IRB) approved use of oral consent

- How oral consent was documented

For more information, please see our guidelines for human subjects research: https://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research

5. In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as: a) the recruitment date range (month and year), b) a description of any inclusion/exclusion criteria that were applied to participant recruitment, c) a table of relevant demographic details, d) a statement as to whether your sample can be considered representative of a larger population.

6. Please include a copy of the interview guide used in the qualitative study, in both the original language and English, as Supporting Information, or include a citation if it has been published previously.

7. Please include additional information regarding the survey or questionnaire used in the cross-sectional study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

8. Please include a discussion of any limitations to your study in the Discussion section.

9. To comply with PLOS ONE submission guidelines, in your Methods section, please provide additional information regarding your statistical analyses. For more information on PLOS ONE's expectations for statistical reporting, please see https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting.

10.Thank you for stating the following in the Acknowledgments Section of your manuscript:

"The study was supported by FAEPEX-Unicamp (Fundo de Apoio ao Ensino, à Pesquisa e à Extensão) under the grant number 2300/20."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

 "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

11. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

12. One of the noted authors is a group or consortium REBRACO Study Group#. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

13.We note that [Figure(s) 1] in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a.    You may seek permission from the original copyright holder of Figure(s) [1] to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

Additional Editor Comments (if provided):

Please address carefully the points below:

1) Clarify (abstract and method section) the study design: is this an observational mixed method study? was there an intervention component?

2) Move the description of the REBRACO initiative (lines 381- 404) in the method section, clarifying to which extent there was an intervention, and when. Do separate activities which related to the study period from activities which has been undertaken after this study

3) Refer to the appropriate guidelines of reporting based on the study design (see https://www.equator-network.org/reporting-guidelines/)

4) Consider revising the title based on the study design and findings, ie, this specific manuscript does not seem to directly aim at exploring how to overcome challenges to adequate care (This would require an intervention study), neither it shows that challenges has been overcomed (table 2) - rather it seems to provide an analysis of the challenges faced by hospitals in a research network and related indicators

5) Clarify the case definition for "MD due to COVID", and, if possible, add details on case characteristics. Adequately comment in the discussion section: how this MD rate compare to the usual MD rates in the included hospitals? where cases clustered or equally distributed among hospitals? where MD most probably due to COVID our to low quality of care?

6) Ensure that all statements in the discussion section have an appropriate reference (eg, line 327 the reference on the Brazilian epidemiological reports is lacking; line 353 the reference open the recent report from Brazil is also missing; line 405 the statement on "major limitation in many settings" miss a reference; please do revise the whole discussion section)

7) Improve the quality of English (eg ask a native English speaker to revise the manuscript)

8) Revise the manuscript according Plos guidelines https://journals.plos.org/plosone/s/submission-guidelines

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Good relevant study with such substantial information added on how to deal with pandemic especially in Low-middle and relevant to high income economies.

Few queries:

Testing challenges; It is mentioned testing was performed full stop; but no further information on how testing was done. For lessons to other parts of the world, it would best to describe how testing was performed. Done by patients themselves or health providers? Inline with testing, any particular lessons we can learn to why there were delays in getting back the results in some centres? It can be questionable if attributable to low resources or fear of sampling and analysis.

Number of cases, challenges and strategies: 29 death attributable to COVD-19; any particular risk factors, co-morbidities ?

Reviewer #2: While the work of the authors in preparing their centers for the care of pregnant women is laudable and to be commended, I am not sure how this paper, other than by describing the REBRACO program, provides any evidence that such a program provided for improved care and led to reduced maternal/neonatal morbidity or mortality. There are no comparisons to any non-REBRACO participating centers and there isn't even a comparison of the maternal death rate during the pandemic months in the REBRACO centres as compared to, say, the same centers during a similar time period before the pandemic. Many such multicenter programs have been set up world wide to better share scarce resources (i.e., PPE), coordinate referrals, better communicate clinical advances and risks and to best document clinical outcomes. While the authors have well reported the clinical outcomes, there needs to be some determination as to whether this approach actually provided for improved clinical outcomes.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jul 23;16(7):e0254977. doi: 10.1371/journal.pone.0254977.r002

Author response to Decision Letter 0


22 Jan 2021

Dear editor,

We acknowledge the detailed evaluation of our study; points raised by the reviewers were important and helped to improve our manuscript.

Bellow, you will find a point-by-point response answering reviewer’s comments. All changes are highlighted (in yellow) in the manuscript.

Sincerely,

Maria Laura Costa, MD, PhD

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

RESPONSE: Thank you. We have checked the style requirements and made the needed modifications.

2. Thank you for including your ethics statement: "Ethical approval for the main study and in each participating center was obtained (Letter of Approval numbers 4.047.168, 4.179.679, and 4.083.988)."

a.Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study.

b.Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research.

RESPONSE: The full name of the ethics committee/institutional review boards that approved the study were included- page 5:

“Ethical approval for the main study and in each participating center was obtained (Letter of Approval numbers 4.047.168, 4.179.679, and 4.083.988, from the coordinating center´s Institutional Review Board from the University of Campinas, the IRB of the School of Medicine of Jundiai, IRB of the Clinics Hospital of Porto Alegre, the IRB of the Unimed Maternity of Belo Horizonte, the IRB of MEAC from the Federal University of Ceara, the IRB of the Federal University of Sao Paulo, IRB of Moinhos de Vento Hospital from Porto Alegre, IRB of the Jorge Rossmann Regional Hospital from Itanhaem, IRB of the Federal University of Sao Carlos, IRB of the State Hospital of Sumare, IR of the Feral University of Minas Gerais, IRB of the Fernandes Figueira Institute from Fiocruz in Rio de Janeiro, IRB of the School of Medicine from the State University of Sao Paulo in Botucatu, IRB of the Federal University of Pernambuco, IRB of the Climerio de Oliveira Maternity from the Federal University of Bahia in Salvador, and the IRB of the Santa Casa de Misericordia do Pará from Belem.”

3. For your cross-sectional study, please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was obtained for the questionnaire (2) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If the need for consent was waived, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent.

4. Regarding verbal consent in your qualitative study, in the Methods, please state:

- Why written consent could not be obtained

- Whether the Institutional Review Board (IRB) approved use of oral consent

- How oral consent was documented

For more information, please see our guidelines for human subjects research: https://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research

RESPONSE: Considering questions 3 and 4- Thank you for your comment and questions. This manuscript represents a great study initiative in Brazil, called REBRACO, with many aims to broadly understand the impact of the COVID-19 in our scenario. Therefore, we have split this major project in three, for ethical approval, dividing the cross-sectional, cohort of suspected cases and qualitative approaches. That is why we presented 3 ethical approval numbers above. We have authorization for both- written informed consent and consent by phone, with authorized recording. Mostly suspected cases with hospital admissions have written informed consent, cases that were evaluated and tested in the emergency room, with no needed admission were later consented by phone. Qualitative studies, especially the one presented here, with health professionals, were done remotely, by phone, since maternities considered are in different parts of the country and all interviews were performed by the same researcher in the coordinating center.

We would like to acknowledge the fact that the current study was based on aggregated data collected via the data collection form that was made available as supporting information and that individual data related to the number of suspected and/or confirmed COVID-19 cases and the related clinical characterization, rate of progression to acute respiratory distress syndrome, and mortality will be properly and timely addressed in another publication of the Consortium.

The information is now clearer in the manuscript, methods, pages 6-7:

“All suspected cases of COVID-19 in the considered maternities were assessed for an informed consent and their data was only included after such consent. The data sharing information on the questionnaire of readiness towards the pandemic and overall numbers of each institution were approved by the coordinating center and locally in each participating center. Data was stored in specific database created for this study and protected by password in a de-identified way. For mild cases not admitted to the hospital, considering biosafety reasons, informed consent by telephone contact was approved by the Institutional Review Board. Participant identity and all personal data as well will remain confidential.”

“We also performed a qualitative component, considering key obstetricians involved in the decision making of each institution, to listen to their perspectives on the challenges to face the pandemic in their setting. Qualitative study by purposeful sampling and saturation sampling was undertaken after individual verbal consent. All semi-structured interviews were performed by a skilled social researcher with experience in the field and were recorded on audio. For this approach, the Institutional Review Board (IRB) approved use of oral consent. Maternities considered are in different regions of the country and all interviews were performed by the same researcher in the coordinating center, by telephone, with a specific software for further transcription and analysis (“ReShape”), protected by password in a de-identified manner.”

5. In your Methods section, please provide additional information about the participant recruitment method and the demographic details of your participants. Please ensure you have provided sufficient details to replicate the analyses such as: a) the recruitment date range (month and year), b) a description of any inclusion/exclusion criteria that were applied to participant recruitment, c) a table of relevant demographic details, d) a statement as to whether your sample can be considered representative of a larger population.

RESPONSE: thank you for your comment, we understand that it was not clear that we here present part of a major study called REBRACO. We have included a paragraph to ascertain that this is now accurate- page 3

“The REBRACO study aims to broadly understand the impact of the COVID-19 in the considered institutions, evaluating clinical, epidemiological and laboratory aspects of SARS-CoV-2 infection during pregnancy and the postpartum (11). The current analysis presents data on how centers faced the pandemic and prepared each institution for the identification and medical care of patients, considering information from January to July 31, 2020.”

Considering the selection of cases for the qualitative component of the current analysis, the local PI identified key health professionals/obstetricians involved in the decision making of each institution and/or responsible for the maternities’ response towards the pandemic. The phone contact to obtain ethical informed consent and the interview were performed by the same research assistant, from the coordinating center. We have added a sentence to the paragraph in page 6:

“We also performed a qualitative component, considering key obstetricians involved in the decision making of each institution, to listen to their perspectives on the challenges to face the pandemic in their setting. These participants were identified by local PIs (principal investigators).”

The details on the cohort of suspected/positive COVID-19 cases, with demographic, clinical, maternal and perinatal outcomes will be further presented in a future analysis. We have included in the discussion, relevant information about Brazil, with data from published studies (from National surveillance system) analyzing clinical characteristics and risk factors for COVID-19-related maternal deaths in the country, that showed the postpartum period, obesity, diabetes, cardiovascular disease and black ethnicity as conditions associated with the fatality rate.

The REBRACO initiative includes 16 maternity hospitals, in 4 of the five regions of the country, mostly University Hospitals, with intensive care support and referral centers for maternal healthcare. Therefore, we understand that it is not representative of the country. Brazil is a country of continental size and most of our centers concentrate in the southeast region. We have included a paragraph in the discussion to add this information.

“The institutions considered in this study, mostly university hospitals and referral centers, had availability for such support, what might not be true or representative of most maternities in Brazil.”

6. Please include a copy of the interview guide used in the qualitative study, in both the original language and English, as Supporting Information, or include a citation if it has been published previously.

RESPONSE: Thank you for the suggestion. We included the semi-structured interview script in both languages (Portuguese and English) as supporting information (S2). The respective reference to the document was included in the methods (Page 3).

7. Please include additional information regarding the survey or questionnaire used in the cross-sectional study and ensure that you have provided sufficient details that others could replicate the analyses. For instance, if you developed a questionnaire as part of this study and it is not under a copyright more restrictive than CC-BY, please include a copy, in both the original language and English, as Supporting Information.

RESPONSE: Thank you for your suggestion. In addition to the detailed description of variables included in the data collection form, we included the data collection form that was sent to the health managers as Supporting Information. This information was included in the methods (Page 5-6).

“The data collection form is provided as Supporting Information (S1). Data were collected with the assistance of the maternity hospital staff. We conducted a descriptive analysis of the information above, including the characteristics of the maternities, their response program, the training program and some indicators related to the COVID-19 pandemic such as the number of cases, number of maternal deaths, maternal mortality ratio due to COVID-19 in the period, time interval between the implementation of the response program and the first suspected COVID-19 cases in each center and the characteristics of the tests available in the obstetric units.”

8. Please include a discussion of any limitations to your study in the Discussion section.

RESPONSE: We have included a paragraph in the discussion, with the main identified limitations of the study. Page 24:

“As a limitation of the current REBRACO study, data from the 16 maternity centers included is not representative of the real maternal health care throughout Brazil, a country of continental size and major disparities. Therefore, the presented results do not provide data to ascertain improved clinical outcomes among considered maternities. In addition, as previously informed, the centers did not follow a common standard protocol for clinically dealing with cases of Covid19 during pregnancy, because only very recently the Ministry of Health issued general recommendations for such management.”

. To comply with PLOS ONE submission guidelines, in your Methods section, please provide additional information regarding your statistical analyses. For more information on PLOS ONE's expectations for statistical reporting, please see https://journals.plos.org/plosone/s/submission-guidelines.#loc-statistical-reporting.

RESPONSE: Thank you for the suggestion. The following information was added to the manuscript in the methods (Page 5-6):

“We conducted a descriptive analysis of the information above, including the characteristics of the maternities, their response program, the training program and some indicators related to the COVID-19 pandemic such as the number of cases, number of maternal deaths, maternal mortality ratio due to COVID-19 in the period, time interval between the implementation of the response program and the first suspected COVID-19 cases in each center and the characteristics of the tests available in the obstetric units.”

“Thematic analysis was finally carried out [12] after the familiarization with the collected data. Then we identified the main themes after generating the initial codes. The themes were reviewed and, finally, they were defined and named according to the main challenges identified in the interviewees’ narratives, with their corresponding experiences, conflicts and answers/actions.”

We would like to acknowledge the fact that we only conducted descriptive and thematic analyses for the quantitative and qualitative components of the study, respectively.

10.Thank you for stating the following in the Acknowledgments Section of your manuscript:

"The study was supported by FAEPEX-Unicamp (Fundo de Apoio ao Ensino, à Pesquisa e à Extensão) under the grant number 2300/20."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

RESPONSE: Thank you. We have now corrected the above text and removed funding-related information from acknowledgements and included the amended statements within our cover letter.

11. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

RESPONSE: We are sorry. The title was corrected in the submission.

12. One of the noted authors is a group or consortium REBRACO Study Group#. In addition to naming the author group, please list the individual authors and affiliations within this group in the acknowledgments section of your manuscript. Please also indicate clearly a lead author for this group along with a contact email address.

RESPONSE: The lead author for this group is Jose Guilherme Cecatti, the last author of this manuscript.

The individual authors and affiliation and the indication of the lead author for each group with a contact e-email address within the respective group were added in the acknowledgments accordingly as suggested.

13.We note that [Figure(s) 1] in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure(s) [1] to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

RESPONSE: Figure 1 was adapted from a map contained in the Brazilian public domain database – Portal Domínio Público (http://www.dominiopublico.gov.br). Thus, the image has no copyright linked to be evidenced. We have included this information in the Figure footnote

Additional Editor Comments (if provided):

Please address carefully the points below:

1) Clarify (abstract and method section) the study design: is this an observational mixed method study? was there an intervention component?

RESPONSE: Thank you. This is an observational mixed method study. We have made that clear in the abstract and methods. There were no interventions.

2) Move the description of the REBRACO initiative (lines 381- 404) in the method section, clarifying to which extent there was an intervention, and when. Do separate activities which related to the study period from activities which has been undertaken after this study

RESPONSE: Thank you. This paragraph is important to add information on the activities of the REBRACO study group. The content of these meetings have inspired the current manuscript, as we learned with each of the local center´s presenting their challenges and ways to overcome them. We have summarized the paragraph and made it clear that there were no interventions. It is now the last paragraph of the methods.

“In the REBRACO initiative, there are no planned interventions in each included centers. All the research team, including local-PIs, health professionals involved in the local Emergency Action Committees, and other collaborators (Ob&Gyn residents, consultants, etc.) from all the included centers, have been invited to participate in weekly virtual meetings, sharing information regarding the organization of the different health services, the barriers and facilitators in the implementation of healthcare and training of health professionals in each center and discussions on current findings on maternal and perinatal outcomes during pregnancy and postpartum of COVID-19 infected women. These meetings have inspired the current analysis.”

3) Refer to the appropriate guidelines of reporting based on the study design (see https://www.equator-network.org/reporting-guidelines/)

RESPONSE: STROBE guideline was followed and included as a supplementary material.

4) Consider revising the title based on the study design and findings, ie, this specific manuscript does not seem to directly aim at exploring how to overcome challenges to adequate care (This would require an intervention study), neither it shows that challenges has been overcomed (table 2) - rather it seems to provide an analysis of the challenges faced by hospitals in a research network and related indicators

RESPONSE: Thank you. You are correct, we have changed the title according to the above suggestion. It now reads: “Facing the COVID-19 Pandemic inside maternities in Brazil: challenges towards adequate care in the REBRACO initiative”

5) Clarify the case definition for "MD due to COVID", and, if possible, add details on case characteristics. Adequately comment in the discussion section: how this MD rate compare to the usual MD rates in the included hospitals? where cases clustered or equally distributed among hospitals? where MD most probably due to COVID our to low quality of care?

RESPONSE: Thank you for the comment and questions. The focus of the current analysis is based on the topics presented. We intend to further detail maternal deaths due to COVID in another analysis and that is why we did not present data specific to reported cases, such as sociodemographic information, clinical background, maternal and perinatal outcomes. We here presented overall numbers, to provide a better picture of the impact of the pandemic. There were 15 maternal deaths due to COVID-19 in the participating centers during the study period. The 29 maternal deaths were due to all causes (and the main cause in Brazil is hypertension). This is described in page 7. Each participating center presented its data according to the information in medical charts.

“There were overall 29 maternal deaths (distributed in only 7 of the 16 centers) and 15 (51.8%) attributed to COVID-19 (in 6 centers), with a Maternal mortality rate (MMR) of 127.8/100.000 LB.”

The discussion if MD were most probably due to COVID or to low quality of care is very complex and we cannot answer it yet, in this manuscript. However, it is important to consider published information about Brazil, with data from our national surveillance system. Data on maternal mortality due to COVID-19 in Brazil showed that up to July 14, 2020, 2,475 cases of COVID‐19 acute respiratory distress syndrome (ARDS) were notified, and among them 204 maternal deaths occurred. Delays in receiving care may have played an important role in fatality rate due to COVID19 among pregnant/postpartum women in our country. Initial “stay at home” recommendation and restrictions on public transportation lengthened hospital admission, characterizing the first delay. Social vulnerability may have led to delays on reaching ICUs, corresponding to the second delay. Lack of thromboprophylaxis after cesarean in high‐risk pregnant women may be an example of the third delay (Menezes, M.O., Takemoto, M.L.S., Nakamura‐Pereira, M., Katz, L., Amorim, M.M.R., Salgado, H.O., Melo, A., Diniz, C.S.G., de Sousa, L.A.R., Magalhaes, C.G., Knobel, R., Andreucci, C.B. and (2020), Risk factors for adverse outcomes among pregnant and postpartum women with acute respiratory distress syndrome due to COVID‐19 in Brazil. Int. J. Gynecol. Obstet., 151: 415-423). We believe that maternal deaths are related both to the severity of coronavirus disease upon obstetric patients, but also due to inappropriate care, including delays.

However, comparing with nationwide data, we understand that the REBRACO study group does not represent healthcare in the country, with most centers in the southeast region and with better maternal and perinatal outcomes, since most centers are University Hospitals, with availability of Intensive Care Support. However, we have highlighted in the discussion, that most cases of MD (12 deaths)- occurred in the North and Northeast regions (worst HDI- Human Development Index), what corroborates to previous data on worse outcomes in under-resourced settings (page 22)

6) Ensure that all statements in the discussion section have an appropriate reference (eg, line 327 the reference on the Brazilian epidemiological reports is lacking; line 353 the reference open the recent report from Brazil is also missing; line 405 the statement on "major limitation in many settings" miss a reference; please do revise the whole discussion section)

Response: The respective references were added and the final list of references was updated. We also revised the discussion section accordingly.

7) Improve the quality of English (eg ask a native English speaker to revise the manuscript)

Response: English has been revised.

8) Revise the manuscript according Plos guidelines https://journals.plos.org/plosone/s/submission-guidelines

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

________________________________________

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: N/A

________________________________________

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

________________________________________

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Good relevant study with such substantial information added on how to deal with pandemic especially in Low-middle and relevant to high income economies.

Few queries:

Testing challenges; It is mentioned testing was performed full stop; but no further information on how testing was done. For lessons to other parts of the world, it would best to describe how testing was performed. Done by patients themselves or health providers? Inline with testing, any particular lessons we can learn to why there were delays in getting back the results in some centres? It can be questionable if attributable to low resources or fear of sampling and analysis.

RESPONSE: We included further information about the tests that had been performed in the REBRACO centers during the study period. The following sentence and the respective Figure was included in the results (Page 9).

“Figure 2 shows the characteristics of the tests performed in the REBRACO centers. In half of the centers (n=8), the tests were not performed in the facility and the characteristics were not available. The characteristic of the RT-PCR and serological tests available were heterogeneous across centers.”

The last paragraph of page 22 and first paragraph of the following page addresses the topics raised by the reviewers.

“A major limitation in many settings, as shown in the current results, is the restricted availability of testing for SARS-CoV-2 and when available, the delayed turnover of results and heterogeneity of the characteristics of the tests across centers.”

“In addition, the heterogeneity of tests make the comparison of the incidence of exposed women to COVID-19 more difficult, which increase challenges on the response to the pandemic using such epidemiological information.”

Number of cases, challenges and strategies: 29 death attributable to COVD-19; any particular risk factors, co-morbidities ?

RESPONSE: Actually, there were 15 maternal deaths due to COVID-19 in the participating centers during the study period. The 29 maternal deaths were due to all causes (and the main cause in Brazil is hypertension). This is described in page 7:

“There were overall 29 maternal deaths (distributed in only 7 of the 16 centers) and 15 (51.8%) attributed to COVID-19 (in 6 centers), with a Maternal mortality rate (MMR) of 127.8/100.000 LB.”

We would like to clarify that we intend to explore the maternal deaths in detail in another analysis which includes the presence of risk-factors, co-morbidities, management characteristics, etc. We thank you for your understanding. However, we have improved the discussion on the scenario and numbers of maternal deaths due to COVID-19 in Brazil and delays associated to such numbers.

Reviewer #2: While the work of the authors in preparing their centers for the care of pregnant women is laudable and to be commended, I am not sure how this paper, other than by describing the REBRACO program, provides any evidence that such a program provided for improved care and led to reduced maternal/neonatal morbidity or mortality. There are no comparisons to any non-REBRACO participating centers and there isn't even a comparison of the maternal death rate during the pandemic months in the REBRACO centres as compared to, say, the same centers during a similar time period before the pandemic. Many such multicenter programs have been set up world wide to better share scarce resources (i.e., PPE), coordinate referrals, better communicate clinical advances and risks and to best document clinical outcomes. While the authors have well reported the clinical outcomes, there needs to be some determination as to whether this approach actually provided for improved clinical outcomes.

RESPONSE: Thank you for this consideration. We understand the title was inadequate and misleading, since there are no interventions reported or analysis to compare outcomes of centers in the REBRACO and out of the research initiative. Our aim was to report challenges on facing the pandemic from centers in a middle-income setting. We presented quantitative and qualitative data to complement the analysis and this is one of the strengths of the paper. At this point, we cannot ascertain that this approach actually provided for improved clinical outcomes, however, we do believe that the participation in a committed group, including health managers, with weekly meetings on the topic and shared experiences can help in overcoming challenges. We have now better explained methods and improved discussion, to make this clear and to point the study limitations.

________________________________________

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No Reviewer #2: No

Attachment

Submitted filename: Response_PloseOne_R1_.docx

Decision Letter 1

Marzia Lazzerini

23 Apr 2021

PONE-D-20-29941R1

Facing the COVID-19 Pandemic inside maternities in Brazil: challenges towards adequate care in the REBRACO initiative

PLOS ONE

Dear Dr. Costa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

One of the 2 referees who revised the paper suggested “REJECTION”, based on the fact that “the paper is primarily descriptive without any comparison to another approach to maternity care during the pandemic. Without an historical or actual comparison to assess whether the changes/programs instituted in the participating centers had any effect on clinical outcomes, we cannot determine whether such changes provided any benefit that could be used now or in the future.  In addition, the paper still requires revision into proper scientific English”and further stated “I am still unclear as to the intent of study/paper.”. The second referee only suggested minor changes.

My opinion is that the paper can contribute by providing description of some changes underwent by the 16 hospitals of the Rebraco initiative in the first period of the pandemic, but it needs major changes to be suitable for publication.   I am here trying to help the paper authors by suggesting some changes that in my view could make the paper more suitable for publication.  

  1. The paper currently lacks a good structure, and element of internal consistency, therefore and difficult to follow. I would suggest to check well consistency in between the study objective sentence> methods > results > discussion. These must be logically aligned. For example, the study objectives in the abstract (lines 4-5) does not mention the qualitative component. 

  2. I suggest adding the study design in the title, this will facilitate reading

  3. Suggestions to improve the abstract_  here, beside revising the sentence on the study objectives,  you need to add key elements currently lacking, such as: 1) study time period ; 2) sample size; 3) more quantitative data (eg data available in Table 2 and 3); 3) avoid in the abstract vague wording such as “Changes in infrastructure and staff were reported” (line 18) or “Training session were less common” (line 20), these sentence adds very little since they are very unspecific and lack quantitative data; 4) be consistent with your study methods, so report key findings both quantitative and qualitative component; 5) the conclusion sentence need to the refer to the study findings, please see other papers as example; a typical sentence would be “study findings suggest that hospital of the REBRACO initiatives underwent major changes…; fear etc (qualitative component). Please note that the abstract is one of the key section of the paper, therefore if you wish to resubmit please consider revising it carefully.

  4. In order to improve the structure of the method section, I would suggest to add in the method section a paragraph for the quantitative component and one for the qualitative component. Both paragraphs would benefit of subparagraphs were all the following key element are clearly described: i) Population and setting, ii) data collection tools and methods, iii) data analysis.

  5. Please check carefully what belongs to each paragraph. For example, the current sentence and the beginning of the results section (lines 172-177) seems to be to pertain to the “study population” in the method section. It’s not clear if the sentence on the sample in lines 127-135 pertains to the quantitative or to the qualitative component.  

  6. The paper currently is very descriptive, often vague and/or not concise. A scientific paper needs to be concise and specific. Please if wishing to resubmit  revise text in order to be concise and specific. I suggest avoid in the paper text and in the abstract vague wording such as “data on several topics such as .. were collected” (line 102) and rather, make explicit exactly what is the list of variables which were collected (this could be done in a Supp Table). Grouping them consistently in methods and results (eg Infrastructures vs Human resources, as already done in Table 2) may also be helpful. Counting them is also helpful; for example, you may say in the method section that you collect data on XX key variable, covering the following domains: infrastructures (XX variables); human resources (XX variables); etc. This would be more concise and more specific that the current text.

  7. Consistency between the method section and the results section in terms of variable reported need to be ensured. Also, consistency in the discussion on key findings of both components need to be there.

  8. Be careful in wording. For example, revise sentences such as “the observational mixed-method component” (line 102). Your study design is mixed methods, and in it you have a quantitative and a qualitative component.

  9. Avoid in the introduction section sentences which rapidly become outdated, such as data on number of people affected by COVID (lines 33-36 and 36-38). Either delete them of make explicit that they refer to your study period.  

  10. The discussion section is quite long. I would suggest to cut it down, delete redundancies and flag out key concepts. Typically, a discussion sections include the following paragraphs: 1) key findings/ what this study adds (very concise, not a repetition of results section), 2) interpretation when comparing to existing literature; 3) study limitations; 4) Recommendations for research 5) recommendations for policy makers    

  11. You can find other inputs on how to improve your paper in the guideline of reporting for both observational cross-sectional studies (STROBE) and qualitative studies (see EQUATOR website). I suggest you bring major changes to your paper by following these guidelines. Please provide the 2 relevant checklists filled in.    

==============================

Please submit your revised manuscript by Jun 07 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Marzia Lazzerini, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

One of the 2 referees who revised the paper suggested “REJECTION”, based on the fact that “the paper is primarily descriptive without any comparison to another approach to maternity care during the pandemic. Without an historical or actual comparison to assess whether the changes/programs instituted in the participating centers had any effect on clinical outcomes, we cannot determine whether such changes provided any benefit that could be used now or in the future. In addition, the paper still requires revision into proper scientific English”and further stated “I am still unclear as to the intent of study/paper.”. The second referee only suggested minor changes.

My opinion is that the paper can contribute by providing description of some changes underwent by the 16 hospitals of the Rebraco initiative in the first period of the pandemic, but it needs major changes to be suitable for publication. I am here trying to help the paper authors by suggesting some changes that in my view could make the paper more suitable for publication.

1) The paper currently lacks a good structure, and element of internal consistency, therefore and difficult to follow. I would suggest to check well consistency in between the study objective sentence> methods > results > discussion. These must be logically aligned. For example, the study objectives in the abstract (lines 4-5) does not mention the qualitative component.

2) I suggest adding the study design in the title, this will facilitate reading

3) Suggestions to improve the abstract_ here, beside revising the sentence on the study objectives, you need to add key elements currently lacking, such as: 1) study time period ; 2) sample size; 3) more quantitative data (eg data available in Table 2 and 3); 3) avoid in the abstract vague wording such as “Changes in infrastructure and staff were reported” (line 18) or “Training session were less common” (line 20), these sentence adds very little since they are very unspecific and lack quantitative data; 4) be consistent with your study methods, so report key findings both quantitative and qualitative component; 5) the conclusion sentence need to the refer to the study findings, please see other papers as example; a typical sentence would be “study findings suggest that hospital of the REBRACO initiatives underwent major changes…; fear etc (qualitative component). Please note that the abstract is one of the key section of the paper, therefore if you wish to resubmit please consider revising it carefully.

4) In order to improve the structure of the method section, I would suggest to add in the method section a paragraph for the quantitative component and one for the qualitative component. Both paragraphs would benefit of subparagraphs were all the following key element are clearly described: i) Population and setting, ii) data collection tools and methods, iii) data analysis.

5) Please check carefully what belongs to each paragraph. For example, the current sentence and the beginning of the results section (lines 172-177) seems to be to pertain to the “study population” in the method section. It’s not clear if the sentence on the sample in lines 127-135 pertains to the quantitative or to the qualitative component.

6) The paper currently is very descriptive, often vague and/or not concise. A scientific paper needs to be concise and specific. Please if wishing to resubmit revise text in order to be concise and specific. I suggest avoid in the paper text and in the abstract vague wording such as “data on several topics such as .. were collected” (line 102) and rather, make explicit exactly what is the list of variables which were collected (this could be done in a Supp Table). Grouping them consistently in methods and results (eg Infrastructures vs Human resources, as already done in Table 2) may also be helpful. Counting them is also helpful; for example, you may say in the method section that you collect data on XX key variable, covering the following domains: infrastructures (XX variables); human resources (XX variables); etc. This would be more concise and more specific that the current text.

7) Consistency between the method section and the results section in terms of variable reported need to be ensured. Also, consistency in the discussion on key findings of both components need to be there.

8) Be careful in wording. For example, revise sentences such as “the observational mixed-method component” (line 102). Your study design is mixed methods, and in it you have a quantitative and a qualitative component.

9) Avoid in the introduction section sentences which rapidly become outdated, such as data on number of people affected by COVID (lines 33-36 and 36-38). Either delete them of make explicit that they refer to your study period.

10) The discussion section is quite long. I would suggest to cut it down, delete redundancies and flag out key concepts. Typically, a discussion sections include the following paragraphs: 1) key findings/ what this study adds (very concise, not a repetition of results section), 2) interpretation when comparing to existing literature; 3) study limitations; 4) Recommendations for research 5) recommendations for policy makers

11) You can find other inputs on how to improve your paper in the guideline of reporting for both observational cross-sectional studies (STROBE) and qualitative studies (see EQUATOR website). I suggest you bring major changes to your paper by following these guidelines. Please provide the 2 relevant checklists filled in.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: (No Response)

Reviewer #3: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Partly

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: No

Reviewer #3: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I thank the authors for their revised manuscript. However, the paper is still primarily a descriptive manuscript without any comparison to another approach to maternity care during the pandemic. Without an historical or actual comparison to assess whether the changes/programs instituted in the participating centers had any effect on clinical outcomes, we cannot determine whether such changes provided any benefit that could be used now or in the future. In addition, the paper still requires revision into proper scientific English.

Reviewer #3: As I was not one of the initial reviewers, i have reviewed both the track changes version of the revised manuscript and the author's responses to prior reviewer comments. Generally I feel the manuscript is adequate in its present version, and look forward to seeing the platform developed through this collaboration used for more substantive contributions in perinatal epidemiology and health services research in the future.

Two minor comments. First, in the tables, be consistent in reporting percent values - these should be to one decimal, and include the trailing zero even when the value is zero (e.g. report 75.0% rather than 75%).

And second, while the manuscript is generally written in good English, a number of sentences are not, throughout the manuscript and especially in the abstract. Therefore I recommend, before finalization, the entire manuscript be reviewed by a scientist with English as a first language.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Reviewer #3: Yes: Russell S. Kirby, College of Public Health, University of South Florida, Tampa, Florida, USA

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jul 23;16(7):e0254977. doi: 10.1371/journal.pone.0254977.r004

Author response to Decision Letter 1


26 Apr 2021

Point-by-Point Responses

Dear editor,

We acknowledge the detailed evaluation of our study.

Bellow, you will find a point-by-point response answering reviewer’s comments. All changes are highlighted (in yellow) in the manuscript.

Sincerely,

Maria Laura Costa, MD, PhD

Reviewer 1-

One of the 2 referees who revised the paper suggested “REJECTION”, based on the fact that “the paper is primarily descriptive without any comparison to another approach to maternity care during the pandemic. Without an historical or actual comparison to assess whether the changes/programs instituted in the participating centers had any effect on clinical outcomes, we cannot determine whether such changes provided any benefit that could be used now or in the future. In addition, the paper still requires revision into proper scientific English”and further stated “I am still unclear as to the intent of study/paper.”

RESPONSE:

We agree that the paper is mostly descriptive and that there is no comparison of time periods- this happened because it was submitted initially in September/2020, with data up to July/2021, during the first wave of the pandemic in Brazil. The aim of the study was to report the challenges in obstetrics and also in under resourced settings, with a quantitative and qualitative approach. The changes described are fundamental to ensure proper healthcare during the pandemic and provide adequate and safe environment both for patients and health workers and represented the prompt response of institutions in a timeframe of much uncertainty, lack of PPE (personal protective equipment) in many settings, need for extra ICU beds and resizing of emergency rooms and medical wards.

At the time of submission, we already pointed towards awareness regarding maternal deaths due to COVID-19 in Brazil and unfortunately this concern, reported in this manuscript with 15 maternal deaths in a 5 months period was further evidenced. National data report a total of 5575 cases of severe COVID-19 disease among pregnant and postpartum women in 2020, with 386 maternal deaths (6.9%) (https://observatorioobstetrico.shinyapps.io/covid_gesta_puerp_br/).

Reviewer 2-

The second referee only suggested minor changes.

RESPONSE: Thank you. Such comments were not reported.

Editor´s suggestions and comments:

My opinion is that the paper can contribute by providing description of some changes underwent by the 16 hospitals of the Rebraco initiative in the first period of the pandemic, but it needs major changes to be suitable for publication. I am here trying to help the paper authors by suggesting some changes that in my view could make the paper more suitable for publication.

RESPONSE: Thank you. We acknowledge all suggestions and have worked to address them and improve the original submission.

1. The paper currently lacks a good structure, and element of internal consistency, therefore and difficult to follow. I would suggest to check well consistency in between the study objective sentence> methods > results > discussion. These must be logically aligned. For example, the study objectives in the abstract (lines 4-5) does not mention the qualitative component.

RESPONSE:

Thank you. We have made significant changes to address consistency throughout the manuscript. The adjusted sentences are highlighted. The aim of the study in the abstract was corrected:

“This study aims to describe the timeframe, implemented strategies and perspectives of health managers on the challenges to face the pandemic in 16 different maternity hospitals that comprise a multicenter study in Brazil, called REBRACO (Brazilian network of COVID-19 during pregnancy).”

2. I suggest adding the study design in the title, this will facilitate reading

RESPONSE:

The title was changed according to the suggestion, to include the study design

“Facing the COVID-19 Pandemic inside maternities in Brazil: a mixed-method study within the REBRACO initiative”

3. Suggestions to improve the abstract_ here, beside revising the sentence on the study objectives, you need to add key elements currently lacking, such as: 1) study time period ; 2) sample size; 3) more quantitative data (eg data available in Table 2 and 3); 3) avoid in the abstract vague wording such as “Changes in infrastructure and staff were reported” (line 18) or “Training session were less common” (line 20), these sentence adds very little since they are very unspecific and lack quantitative data; 4) be consistent with your study methods, so report key findings both quantitative and qualitative component; 5) the conclusion sentence need to the refer to the study findings, please see other papers as example; a typical sentence would be “study findings suggest that hospital of the REBRACO initiatives underwent major changes…; fear etc (qualitative component). Please note that the abstract is one of the key section of the paper, therefore if you wish to resubmit please consider revising it carefully.

RESPONSE:

Thank you. All information was included/adjusted accordingly and detailed bellow in italic.

1) study time period: from January to July/2020 (line 11);

2) sample size: for the qualitative study: “A qualitative study by purposeful and saturation sampling was undertaken with healthcare managers”; for the quantitative study, we considered all cases of COVID-19 reported by each participating center and their information on total number of deliveries, livebirth, maternal deaths.

3) more quantitative data (eg data available in Table 2 and 3. avoid in the abstract vague wording such as “Changes in infrastructure and staff were reported” (line 18) or “Training session were less common” (line 20), these sentence adds very little since they are very unspecific and lack quantitative data;

The required information was added: All maternities performed relocation of beds designated to labor ward, most (75%) acquired mechanical ventilators, only the minority (25%) installed new negative air pressure rooms. Considering human resources, around 40% hired extra health professionals and increased weekly workload and the majority (68.7%) also suspended annual leaves. Only one center implemented universal screening for childbirth. Qualitative results showed that main challenges experienced were related to the fear of the virus, concerns about reliability of evidence, lack of resources and clear need for mental health support among health professionals.

4) be consistent with your study methods, so report key findings both quantitative and qualitative component- Improved as reported above.

5) the conclusion sentence need to the refer to the study findings, please see other papers as example; a typical sentence would be “study findings suggest that hospital of the REBRACO initiatives underwent major changes…; fear etc (qualitative component). Please note that the abstract is one of the key section of the paper, therefore if you wish to resubmit please consider revising it carefully.

Thank you. Conclusion now refers to main study findings:

“Study findings suggest that maternities of the REBRACO initiative underwent major changes in facing the pandemic, mostly resizing emergency rooms, relocating beds and adding extra ICU units and new ventilators. On human resources, most centers had to employ increased weekly workloads and listening to health managers, main concerns included fear of the virus and lack of resources. In the first months of the pandemic, there were 15 maternal deaths due to COVID-19 in the reported centers.”

4. In order to improve the structure of the method section, I would suggest to add in the method section a paragraph for the quantitative component and one for the qualitative component. Both paragraphs would benefit of subparagraphs were all the following key element are clearly described: i) Population and setting, ii) data collection tools and methods, iii) data analysis.

RESPONSE:

Thank you. We have now organized methods in two subgroups (quantitative component and qualitative component) with the required information.

5. Please check carefully what belongs to each paragraph. For example, the current sentence and the beginning of the results section (lines 172-177) seems to be to pertain to the “study population” in the method section. It’s not clear if the sentence on the sample in lines 127-135 pertains to the quantitative or to the qualitative component.

RESPONSE:

Thank you. We agree, the first sentence in results belongs to methods and was excluded.

The information on informed consent for each component of the study is now more clear in the methods, with the previous suggestion of better defining quantitative and qualitative approaches (with sub-headings added).

6. The paper currently is very descriptive, often vague and/or not concise. A scientific paper needs to be concise and specific. Please if wishing to resubmit revise text in order to be concise and specific. I suggest avoid in the paper text and in the abstract vague wording such as “data on several topics such as .. were collected” (line 102) and rather, make explicit exactly what is the list of variables which were collected (this could be done in a Supp Table). Grouping them consistently in methods and results (eg Infrastructures vs Human resources, as already done in Table 2) may also be helpful. Counting them is also helpful; for example, you may say in the method section that you collect data on XX key variable, covering the following domains: infrastructures (XX variables); human resources (XX variables); etc. This would be more concise and more specific that the current text.

RESPONSE:

Thank you. We have included all suggestions in the text and added the Supporting Box bellow with the data requested”. The paragraph now is:

“For the quantitative component, we collected data on the infrastructure/equipment of the units, maternal and perinatal health indicators, characteristics of service provision and modifications on staff and human resources. Detailed material can be found in the Supporting Information (S1)”.

Supporting information-S1

S1: Variables requested for the characterization of the included REBRACO centers. List of variables which were collected through online forms

Infrastructure/Equipment

Number of beds designated for labor ward (per month, from March to August)

Number of beds designated for obstetric medical ward (per month, from March to August)

Number of beds designated for intensive care (per month, from March to August)

Availability of the tests to confirm the infection by SARS-CoV 2 and number of tested women (per month, from March to August)

Implementation of modifications in the maternity´s infra-structure (resizing wards, relocation of beds, acquiring new equipments, such as ventilators)

Availability of PPE (Personal Protective Equipment)

Maternal and perinatal health indicators

Total number of attendances at the obstetric emergency care unit (per month, from March to August)

Number of attendances at the obstetric emergency care unit (per month, from March to August) for pregnant and postpartum women with suspected COVID-19

Number of new confirmed cases of COVID-19 in pregnant and postpartum women (per month, from March to August)

Criteria for suspected cases of COVID-19

Number of hospitalizations of pregnant and postpartum women in the unit (per month, from March to August)

Number of hospitalizations due to COVID-19 in pregnant and postpartum women in the unit (per month, from March to August) (suspected or confirmed)

Number of new cases of severe acute respiratory syndrome (SARS) in pregnant/postpartum women, in the unit (per month, from March to August)

Number of new cases of severe acute respiratory syndrome (SARS) caused by COVID-19 in pregnant/postpartum women, in the unit (per month, from March to August)

Number of maternal deaths due to all causes in the unit (per month, from March to August)

Number of maternal deaths due to COVID-19 unit (per month, from March to August)

Number of live births in you unit (per month, from March to August)

Cesarean section rate (%; elective or intrapartum cesarean) in the unit (per month, from March to August)

Number of live births in the municipality unit (per month, from March to August)

Number of stillbirths in the unit (per month, from March to August)

Number of stillbirths in the municipality unit (per month, from March to August)

Other characteristics of service provision

Referral center for cases suspected/confirmed for COVID-19 (y/n)

Rules on the presence of companions during childbirth (always, often, sometimes, rarely or never; per month, from March to August)

How long on average was the turnover to obtain test results for COVID-19? (in days; per month, from March to August)

Gynecological and obstetrical services according to the usual standard in the unit (suspended, reduction, no change, not applicable)

Staff/Human Resources

Presence of Ob&Gyn medical residents (y/n)

Number of professionals that received sick leave due to COVID-19 in the unit (per month, from March to August)

Members of the COVID-19 Emergency Action Committee (EAC) - (according to type of health professionals) and date of EAC implementation (from January to August)

Modification of work schedule of health professionals (Hiring new professionals, increase in weekly workload, suspension of annual leaves)

Content of the training program for COVID-19

7. Consistency between the method section and the results section in terms of variable reported need to be ensured. Also, consistency in the discussion on key findings of both components need to be there.

RESPONSE:

Thank you. We have revised the manuscript for consistency, included data that were not reported in tables (table 1 was revised) and better reported results and organized the discussion.

This paragraph is now referred to table 1, for example:

“All maternities established a local Covid-19 Emergency Action Committee (EAC) and implemented a local protocol for contingency and management of COVID-19 in pregnancy. The EAC was usually comprised of a general practitioner or internal medicine (73% of the centers, n=11), Obstetrics and Gynecology specialist (75%, n=12), intensive care specialist (68.7%, n=11), nurse (75%, n=12), member of the Infection Prevention and Control Committee (75%, n=12), administrative assistant (68.7%, n=11), and, less often, of a physiotherapist (31.2%, n=5) (Table 1). All the 16 maternities had access to diagnostic laboratory testing. However, only 6 maternities (37.5%) had resources to test any suspected case of COVID-19.”

8. Be careful in wording. For example, revise sentences such as “the observational mixed-method component” (line 102). Your study design is mixed methods, and in it you have a quantitative and a qualitative component.

RESPONSE:

Thank you. We have corrected the wording throughout the manuscript.

9. Avoid in the introduction section sentences which rapidly become outdated, such as data on number of people affected by COVID (lines 33-36 and 36-38). Either delete them of make explicit that they refer to your study period.

RESPONSE:

We agree and have modified the paragraph to avoid too many numbers and include only data consistent with the considered study period, in Brazil.

“Coronavirus disease 2019 (COVID-19) has threatened the world, since March 2020, when the pandemic was officially declared by the WHO (World Health Organization) [1]. Some countries were especially affected and faced individual challenges towards viral dissemination. Brazil was certainly one of those, recognized as a pandemic hotspot with more than 4.1 million people infected and over 126,000 deaths, in the first 6 months of the pandemic”

10. The discussion section is quite long. I would suggest to cut it down, delete redundancies and flag out key concepts. Typically, a discussion sections include the following paragraphs: 1) key findings/ what this study adds (very concise, not a repetition of results section), 2) interpretation when comparing to existing literature; 3) study limitations; 4) Recommendations for research 5) recommendations for policy makers

RESPONSE:

Thank you. We have reviewed discussion, excluded redundancies (three paragraphs) and better organized ideas, according to the suggestions above.

Now, the first paragraph addresses the key findings:

“The 16 maternities of the REBRACO initiative were mostly university hospitals, which underwent major changes and adaptations in facing the first few months of the pandemic, resizing emergency rooms, relocating beds and adding extra ICU units, with acquisition of ventilators. On human resources, most centers had to employ increased weekly workloads, deal with medical leave due to COVID infections, and hire extra health professionals. Listening to health managers, main concerns included fear of the virus and lack of resources. There was a clear limitation in the capacity of testing during the considered study period, less than half of the centers had resources to test any suspected case of COVID-19.”

We again, acknowledge all suggestions and hope that the revised version of the manuscript is suitable for publication.

Best regards,

Maria Laura Costa

Attachment

Submitted filename: Response_PloseOne_R2_.docx

Decision Letter 2

Marzia Lazzerini

18 May 2021

PONE-D-20-29941R2

Facing the COVID-19 Pandemic inside maternities in Brazil: a mixed-method study within the REBRACO initiative

PLOS ONE

Dear Dr. Costa,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

============================== 

The paper has improved a lot, but need further improvement. Again, I will give here some suggestions on how to improve it:

ABSTRACT

Line 4: is the “the timeframe” really one of the indicators? Where is it in results? Otherwise delete from abstract and also from the text 

Line 7-10. Find a way to be more concise  on quantitative indicators.

Line 12 versus line 4: either use the word “perspective” (line 4) or “local challenges” (line 12). The 2 words do not have the same meaning. Or should it be perspectives on local challenges?

Line 14: delete “Rebraco centers respond for a total of 4000 deliveries/months “ or move it to introduction

Line 21 “while most only tested” : once again I advise to avoid using unspecific words such as most

Conclusion: line 26-30 are just a repetition of study findings, delete these and add in conclusion recommendations for policy makers and for further research.  

INTRO

Line 42-45   are not relevant to your research question. Please revise to make clear what are the knowledge gaps related to HS and why is your research question relevant

Line 59: you state that the REBRACO collect qualitative data from women experiences, but there is no further mention on this in the paper

Line 63-65. Add that you also collected perspectives of HW

METHODS

Line 67-69 and 73-75 are a repetition of lines 54-57. I suggest to place the background information on REBRACO in the Introduction. Here in methods add details on study population and settings- Move here lines 165-169

Line 76-78 and 99-101 repeated the study objectives again

Line 102-132 and 133-162 These sections still lack some structure. Please first describe what data you collected, then how, and then how the analysis performed. Separate paragraphs so that they are clearly identified

Table 1. there are only few quantitative indicators on your research question in this table, consider adding in tables data that now are in the text

CONCLUSION

Still very long, please reduce length

==============================

Please submit your revised manuscript by Jul 02 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Marzia Lazzerini, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

The paper has improved a lot, but need further improvement. Again, I will give here some suggestions on how to improve it:

ABSTRACT

Line 4: is the “the timeframe” really one of the indicators? Where is it in results? Otherwise delete from abstract and also from the text

Line 7-10. Find a way to be more concise on quantitative indicators.

Line 12 versus line 4: either use the word “perspective” (line 4) or “local challenges” (line 12). The 2 words do not have the same meaning. Or should it be perspectives on local challenges?

Line 14: delete “Rebraco centers respond for a total of 4000 deliveries/months “ or move it to introduction

Line 21 “while most only tested” : once again I advise to avoid using unspecific words such as most

Conclusion: line 26-30 are just a repetition of study findings, delete these and add in conclusion recommendations for policy makers and for further research.

INTRO

Line 42-45 are not relevant to your research question. Please revise to make clear what are the knowledge gaps related to HS and why is your research question relevant

Line 59: you state that the REBRACO collect qualitative data from women experiences, but there is no further mention on this in the paper

Line 63-65. Add that you also collected perspectives of HW

METHODS

Line 67-69 and 73-75 are a repetition of lines 54-57. I suggest to place the background information on REBRACO in the Introduction. Here in methods add details on study population and settings- Move here lines 165-169

Line 76-78 and 99-101 repeated the study objectives again

Line 102-132 and 133-162 These sections still lack some structure. Please first describe what data you collected, then how, and then how the analysis performed. Separate paragraphs so that they are clearly identified

Table 1. there are only few quantitative indicators on your research question in this table, consider adding in tables data that now are in the text

CONCLUSION

Still very long, please reduce length

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Jul 23;16(7):e0254977. doi: 10.1371/journal.pone.0254977.r006

Author response to Decision Letter 2


20 May 2021

Dear editor,

We again acknowledge the detailed evaluation of our study. We agree that all previous suggestions and comments have greatly improved the manuscript: “Facing the COVID-19 Pandemic inside maternities in Brazil: a mixed-method study within the REBRACO initiative”.

Bellow, you will find a point-by-point response answering reviewer’s comments. All changes are highlighted (in yellow) in the manuscript.

Sincerely,

Maria Laura Costa, MD, PhD

Reviewer -

The paper has improved a lot, but need further improvement. Again, I will give here some suggestions on how to improve it:

ABSTRACT

Line 4: is the “the timeframe” really one of the indicators? Where is it in results? Otherwise delete from abstract and also from the text

RESPONSE: We agree, the term was confusing. We have deleted. The aim now is:

“This study aims to describe the strategies implemented and the perspectives of health managers on the challenges to face the pandemic in 16 different maternity hospitals that comprise a multicenter study in Brazil, called REBRACO (Brazilian network of COVID-19 during pregnancy).

It was also deleted from the text.

Line 7-10. Find a way to be more concise on quantitative indicators.

RESPONSE: Thank you. We have made it more concise. It now reads:

“Mixed-method study, with quantitative and qualitative approaches. Quantitative data on the infrastructure of the units, maternal and perinatal health indicators, modifications on staff and human resources, from January to July/2020. Also, information on total number of cases, and availability for COVID-19 testing. A qualitative study by purposeful and saturation sampling was undertaken with healthcare managers, to understand perspectives on local challenges in facing the pandemic.”

Line 12 versus line 4: either use the word “perspective” (line 4) or “local challenges” (line 12). The 2 words do not have the same meaning. Or should it be perspectives on local challenges?

RESPONSE: Thank you. We believe the most accurate would be “perspectives on local challenges”. We have changed the text.

Line 14: delete “Rebraco centers respond for a total of 4000 deliveries/months “ or move it to introduction

RESPONSE: It was deleted.

Line 21 “while most only tested” : once again I advise to avoid using unspecific words such as most

RESPONSE: Thank you. We have included the complete information:

“while around 60% of the centers only tested moderate/severe cases with hospital admission”

Conclusion: line 26-30 are just a repetition of study findings, delete these and add in conclusion recommendations for policy makers and for further research.

RESPONSE: Thank you. We have adjusted the conclusion in order to address main findings and recommendations for policy makers and for further research.

“Study findings suggest that maternities of the REBRACO initiative underwent major changes in facing the pandemic, with limitations on testing, difficulties in infrastructure and human resources. Leadership, continuous training, implementation of evidence-based protocols and collaborative initiatives are key to transpose the fear of the virus and ascertain adequate healthcare inside maternities, especially in low and middle-income settings. Policy makers need to address the specificities in considering reproductive health and childbirth during the COVID-19 pandemic and prioritize research and timely testing availability.”

INTRO

Line 42-45 are not relevant to your research question. Please revise to make clear what are the knowledge gaps related to HS and why is your research question relevant

RESPONSE: Thank you, it really was not clear. The sentence needs to present the challenge that the country size, economic and political crises can add to a pandemic. We have changed it to:

“Brazil is an upper-middle-income country of continental size, with great social and economic disparities among different regions, and major political crisis. These characteristics enhance the challenges in facing a pandemic”.

Line 59: you state that the REBRACO collect qualitative data from women experiences, but there is no further mention on this in the paper

RESPONSE: Thank you. We have adjusted the text to make sure that it is clear that we are describing the main study, and how the initiative was built, with the reference for the overall protocol (actually a Letter that describes the main objectives of the project, as a “call to action”). Therefore, in the current analysis we only included the qualitative data on health professionals.

“Overall, the REBRACO initiative aimed at evaluating the clinical, epidemiological and laboratory aspects related to SARS-CoV-2 infection during pregnancy, besides a qualitative assessment of women and professionals experiencing such a situation, to identify maternal and perinatal outcomes and collect relevant information to provide quick responses and proper organization of health services to confront the COVID-19 pandemic [11].

As part of the main study, we aim to describe the strategies implemented and the perspectives of health managers on the challenges to face the pandemic in 16 different maternity hospitals …”

Line 63-65. Add that you also collected perspectives of HW

RESPONSE: we have added the information on HW perspectives.

METHODS

Line 67-69 and 73-75 are a repetition of lines 54-57. I suggest to place the background information on REBRACO in the Introduction. Here in methods add details on study population and settings- Move here lines 165-169

RESPONSE: Thank you. We have deleted repeated information.

Line 76-78 and 99-101 repeated the study objectives again

RESPONSE: Repetition was deleted.

Line 102-132 and 133-162 These sections still lack some structure. Please first describe what data you collected, then how, and then how the analysis performed. Separate paragraphs so that they are clearly identified

RESPONSE: Thank you. We agree that information was not well organized. We have structured as suggested.

“For the quantitative component, we collected data on the infrastructure/equipment of the units, maternal and perinatal health indicators, characteristics of service provision and modifications on staff and human resources. All information was retrieved through an electronic form developed by the coordinating center and sent by e-mail to the Principal Investigator of each center (Health Manager, responsible for the Obstetrical Emergency Action Committee - EAC - in each institution). The data collection form is provided as Supporting Information (S1) and includes data on: characteristics of the maternities, their response program, their training program and some indicators related to the COVID-19 pandemic such as the number of cases, number of maternal deaths, maternal mortality ratio due to COVID-19 in the period, the time interval between the implementation of the response program and the first suspected COVID-19 cases in each center and the characteristics of the tests available in the obstetric units.

All suspected cases of COVID-19 in the considered maternities were assessed for informed consent and their data was only included after such consent, with identity kept confidential. Considering biosafety reasons, the study has authorization, by the Institutional Review Board, for both- written informed consent and consent by phone to use information from medical records and sample collection. Mostly suspected cases with hospital admissions have written informed consent, cases that were evaluated and tested in the emergency room, with no needed admission were later consented by phone. The researcher read and explained the consent form and assured that women could withdraw from the study without any interference with planned medical care. All interviews were recorded on audio after consent from the participants, using the Microsoft Skype platform.“

Table 1. there are only few quantitative indicators on your research question in this table, consider adding in tables data that now are in the text

RESPONSE: We have adjusted the Table description in order to present clearly the results:

“Table 1. Characteristics of included maternities in the REBRACO study (n=16), participating members of the local Emergency Action Committees (EAC) and information on COVID-19 infection and some healthcare indicators.”

CONCLUSION

Still very long, please reduce length

RESPONSE: it was reduced.

“Study findings suggest that maternities of the REBRACO initiative underwent major changes in facing the pandemic, with limitations on testing, difficulties in infrastructure and human resources. Leadership, continuous training, implementation of evidence-based protocols and collaborative initiatives are key to transpose the fear of the virus and ascertain adequate healthcare inside maternities, especially in low and middle-income settings. Policy makers need to address the specificities in considering reproductive health and childbirth during the COVID-19 pandemic and prioritize research and timely testing availability.”

We again, acknowledge all suggestions and hope that the revised version of the manuscript is suitable for publication.

Best regards,

Maria Laura Costa

Attachment

Submitted filename: Response_PloseOne_R3.docx

Decision Letter 3

Marzia Lazzerini

8 Jul 2021

Facing the COVID-19 Pandemic inside maternities in Brazil: a mixed-method study within the REBRACO initiative

PONE-D-20-29941R3

Dear Dr. Costa,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Marzia Lazzerini, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

After the lasT revision I feel that the paper is suitable fopr publication if:

- yuo add when data were collected (ie,month, year)

- check is sentence on line 116-117 is pertinent to qunatittaive data collection ("All interviews were recorded on audio after consent 117 from the participants, using the Microsoft Skype platform" Explain how interviews were pertinent to quantittaive data)

Reviewers' comments:

Acceptance letter

Marzia Lazzerini

16 Jul 2021

PONE-D-20-29941R3

Facing the COVID-19 Pandemic inside maternities in Brazil: a mixed-method study within the REBRACO initiative

Dear Dr. Costa:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Marzia Lazzerini

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. STROBE statement—checklist of items that should be included in reports of observational studies.

    (DOCX)

    S1 Data. Variables requested for the characterization of the included REBRACO centers.

    List of variables which were collected through online forms.

    (DOCX)

    S2 Data. Data collection form.

    Information about the organization, health care and consolidated results of the REBRACO participating centers (from March to August).

    (DOCX)

    S3 Data. Interview script.

    Semi-structured interview script for health managers, used on the qualitative study.

    (DOCX)

    Attachment

    Submitted filename: Response_PloseOne_R1_.docx

    Attachment

    Submitted filename: Response_PloseOne_R2_.docx

    Attachment

    Submitted filename: Response_PloseOne_R3.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES